Top

Carlos Antonio Torres-Cabala, M.D.

Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

About Dr. Torres-Cabala

I am a Professor in the Departments of Pathology and Dermatology at MD Anderson Cancer Center. I am board certified in Anatomic Pathology (National Cancer Institute, Bethesda, MD) and Dermatopathology (UT MD Anderson Cancer Center) and have a previous residency in Anatomic and Clinical Pathology (Universidad Cayetano Heredia, Lima, Peru). I also obtained a PharmD parallel to my MD studies in Peru, where I completed MS studies in Biochemistry and Molecular Biology.

My research interests comprise cutaneous tumors with emphasis in lymphomas and melanoma. In lymphomas I have conducted studies in rare aggressive primary cutaneous tumors such as gamma/delta T cell lymphoma (expanding the description of the epidermotropic variant) as well as more indolent entities such as lymphomatoid papulosis (type D) and CD4-positive small to medium size T cell lymphoproliferative disorders. In melanoma, i have focused in acral lentiginous melanoma for which we described KIT mutation and protein expression status in a large series of cases and described TERT amplification in progression to metastasis. I have presented my research and taught in many national and international conferences and courses. Currently, I served as Section Chief of Dermatopathology and I am a member of the executive committee of the International Society of Dermatopathology.

Primary Appointment

Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Pathology, University of Texas Medical Branch, Galveston, TX

Education & Training

Degree-Granting Education

1994	Universidad Nacional de San Agustin, School of Medicine, Arequipa, PER, MD, Medicine
1992	Universidad Catolica Santa Maria, School of Pharmacy and Biochemistry, Arequipa, PER, PharmD, Pharmacy and Biochemistry

Postgraduate Training

2007-2008	Clinical Fellowship, Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
2004-2007	Clinical Residency, Anatomic Pathology, National Institutes of Health, National Cancer Institute, Bethesda, MD
2001-2004	Postdoctoral Research Fellowship, Molecular Pathology, Urologic Oncology and Pathology, National Institutes of Health, National Cancer Institute, Bethesda, MD
1996-2000	Clinical Residency, Anatomic and Clinical Pathology, Universidad Peruana Cayetano Heredia, Hospital Nacional Cayetano Heredia, Lima
1993-1994	Clinical Internship, Universidad Nacional de San Agustin School of Medicine, Arequipa

Board Certifications

2008	American Board of Pathology and American Board of Dermatology, Dermatopathology
2007	American Board of Pathology, Anatomic Pathology

Experience & Service

Administrative Appointments/Responsibilities

Co-Director, Department of Translational Molecular Pathology Dermatopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present

Member, Membership Awards Committee, The American Society of Dermatopathology, Deerfield, IL, 2017 - 2019

Chief, Dermatopathology Section, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present

Member, Executive Committee, International Society of Dermatopathology, Half Moon Bay, CA, 2013 - Present

Member, The American Society of Dermatopathology, Deerfield, IL, 2011 - 2015

Secretary/Treasurer, Latin American Pathology Foundation, New Orleans, LA, 2009 - 2010

Other Appointments/Responsibilities

Collaborator, Core B, Informatics, Tissue Resource and Pathology Core, Melanoma SPORE, Houston, TX, 2008 - Present

Institutional Committee Activities

Member, The University of Texas MD Anderson Cancer Center Bridge Funding Advisory Committee, 2020 - Present

Member, The University of Texas MD Anderson Cancer Center Clinical Research Committee (CRC) 4, 2012 - 2015

Member, Study Section Review Committee for Clinical Translational and Population-Based Research Projects under the Institutional Research Grants (IRG) Program, 2011 - Present

Representative, Department of Pathology, Faculty Senate of The University of Texas MD Anderson Cancer Center, 2011 - 2014

Member, The University of Texas MD Anderson Cancer Center Clinical Research Committee (CRC) 2, 2010 - 2012

Dermatopathology Representative, Department of Pathology Committee for the ACGME Site Visit/Evaluation of The University of Texas MD Anderson Cancer Center Special Surgical Pathology Fellowship Program, 2010 - Present

Consultantships

The University of Texas MD Anderson Cancer Center Representative, National Comprehensive Cancer Network (NCCN), Fort Washington, PA, 2018 - Present

Outside Reviewer, Medical translation of educational materials (English/Spanish), American Cancer Society, Cedar Park, Texas, 2010 - Present

Honors & Awards

2020	Faculty Recognition Award for Excellence in Patient Care, inaugural recipient, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
2006	Travel Award, International Society of Urological Pathology
2004	Merit Stowell-Orbison Award, United States and Canadian Academy of Pathology

Professional Memberships

Mentorship Program Committee, Peruvian American Medical Society

Member, 2022 - Present

Iberoamerican Association of Telehealth and Telemedicine

Associate Member, 2022 - Present

International Society of Cutaneous Lymphomas

Member, 2020 - Present

United States Cutaneous Lymphoma Consortium

Member, 2017 - Present

American Society of Dermatopathology

Member, 2013 - Present

International Society of Dermatopathology

Member, 2009 - Present

Latin American Pathology Foundation

Secretary/Treasurer, 2009 - 2010

Harris County Medical Society

Member, 2008 - Present

Texas Medical Association

Member, 2008 - Present

American Society for Clinical Pathology

Member, 2007 - Present

College of American Pathologists

Member, 2006 - Present

American Medical Association

Member, 2006 - Present

International Union Against Cancer (UICC)

Member, 2004 - 2009

Peruvian American Medical Society

Member, 2004 - Present

American Society for Investigative Pathology

Member, 2003 - 2009

United States and Canadian Academy of Pathology (USCAP)

Member, 2002 - Present

Edmundo Escomel Scientific Association

Secretary, 1990 - 1996

Selected Publications

Peer-Reviewed Articles

Cho WC, Li W, Gu J, Wang WL, Ning J, Sfamenos S, Gill P, Nagarajan P, Curry JL, Lazar AJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma. J Cutan Pathol 50(9):845-851, 2023. e-Pub 2023. PMID: 37400233.
Vanderbeck K, Rothrock AT, Cho WC, Nagarajan P, Aung PP, Hudgens C, Bassett RL, Ivan D, Prieto VG, Curry JL, Torres-Cabala CA. PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls. Am J Dermatopathol 45(8):549-556, 2023. e-Pub 2023. PMID: 37462205.
Marques-Piubelli ML, Seervai RNH, Mudaliar KM, Ma W, Milton DR, Wang J, Muhlbauer A, Parra ER, Solis LM, Nagarajan P, Speiser J, Hudgens C, Cho WC, Aung PP, Patel A, Pacha O, Nelson KC, Tetzlaff MT, Amaria RN, Torres-Cabala CA, Prieto VG, Wistuba II, Curry JL. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of TH 1 T-cells. J Cutan Pathol 50(7):661-673, 2023. e-Pub 2023. PMID: 37150813.
Song KY, Han YH, Roehrich H, Brown ME, Torres-Cabala C, Giubellino A. MET Receptor Tyrosine Kinase Inhibition Reduces Interferon-Gamma (IFN-γ)-Stimulated PD-L1 Expression through the STAT3 Pathway in Melanoma Cells. Cancers (Basel) 15(13), 2023. e-Pub 2023. PMID: 37444518.
Liu YA, Dai J, Nagarajan P, Torres-Cabala CA, Aung PP, Prieto VG, Cho WC. Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature Review. Am J Dermatopathol 45(3):185-188, 2023. e-Pub 2023. PMID: 36626570.
Niu N, Heberton MM, Tang Z, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review. J Cutan Pathol. e-Pub 2023. PMID: 36944579.
Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma. Arch Pathol Lab Med. e-Pub 2023. PMID: 36745184.
Cho WC, Ding Q, Wang WL, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Albarracin CT, Sahin A, Prieto VG, Aung PP. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics. J Cutan Pathol. e-Pub 2023. PMID: 36808637.
Vanderbeck K, Cho WC, Aung PP, Ivan D, Rothrock AT, Torres-Cabala CA, Prieto VG, Curry JL, Nagarajan P. Ductal differentiation: A rare phenomenon in Merkel cell carcinoma. J Cutan Pathol. e-Pub 2022. PMID: 36454019.
Hasanov M, Milton DR, Bea Davies A, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen R, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg J, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes In Outcomes And Factors Associated With Survival In Melanoma Patients With Brain Metastases. Neuro Oncol. e-Pub 2022. PMID: 36510640.
Amaria RN, Postow M, Burton EM, Tezlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611(7934):155-160, 2022. e-Pub 2022. PMID: 36289334.
Rothrock AT, Hameed N, Cho WC, Nagarajan P, Ivan D, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes. J Cutan Pathol. e-Pub 2022. PMID: 36377266.
Seervai RNH, Friske SK, Chu EY, Phillips R, Nelson KC, Huen A, Cho WC, Aung PP, Torres-Cabala CA, Prieto VG, Curry JL. The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapy. J Cutan Pathol. e-Pub 2022. PMID: 36069496.
Guitart J, Mangold AR, Martinez-Escala ME, Walker CJ, Comfere NI, Pulitzer M, Rieger KE, Torres-Cabala CA, Pincus LB, Kumar ES, Wang EBK, Park KE, Espinosa ML, Duvic M, Kim YH, Horwitz S. Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders. JAMA Dermatol. e-Pub 2022. PMID: 36001337.
Bartley B*, Cho WC, Rady PL, Dai J, Curry JL, Milbourne A, Tyring SK, Torres-Cabala CA. Condyloma and coincidental epidermodysplasia verruciformis (EDV) acanthoma positive for human papillomavirus-14 and -21. (*Mentor of a medical student). J Cutan Pathol. e-Pub 2022. PMID: 36039682.
Rothrock AT, Torres-Cabala CA, Milton DR, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Ivan D, Prieto VG, Aung PP. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions. J Cutan Pathol. e-Pub 2022. PMID: 35794643.
Cho WC, Nagarajan P, Ding Q, Prieto VG, Torres-Cabala CA. Trichorhinophalangeal Syndrome Type 1-Positive Cells in Breast Dermal Granulation Tissues and Scars: A Potential Diagnostic Pitfall. Am J Dermatopathol. e-Pub 2022. PMID: 35925150.
Rothrock AT, Truong LD, Shehabeldin A, Wong MKK, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Amyloid deposition with a granulomatous reaction in a resection specimen: A clue for a preexisting Merkel cell carcinoma. J Cutan Pathol. e-Pub 2022. PMID: 35734844.
Fang H, Khoury JD, Torres-Cabala CA, Ng SB, Xu J, El Hussein S, Hu S, Vega F, Li S, Tang Z, Tang G, Medeiros LJ, Wang W. Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms. Pathology. e-Pub 2022. PMID: 35864006.
Joshi TP, Duvic M, Torres-Cabala CA, Tschen J. Treatment With Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma. JAMA Dermatol. e-Pub 2022. PMID: 35416914.
Farah M, Milton , Gross ND, Nagarajan P, Gu J, Curry JL, Ivan D, Torres-Cabala CA, Myers JN, Prieto VG, Aung PP. Histopathologic Features Predictive of Metastasis and Survival in 230 Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck and Non-Head and Neck Locations: A Single-Center Retrospective Study. J Eur Acad Dermatol Venereol. e-Pub 2022. PMID: 35426183.
Mantilla-Rojas C, Velasquez FC, Morton JE, Clemente LC, Parra ER, Torres-Cabala C, Sevick-Muraca EM. Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy. Cancers (Basel) 14(7), 2022. e-Pub 2022. PMID: 35406595.
Cho WC, Gill P, Nagarajan P, Aung PP, Torres-Cabala CA, Curry JL, Ivan D, Lester L, Prieto VG. Cutaneous Lymphoid Hyperplasia With T-Cell Clonality and Monotypic Plasma Cells Secondary to a Tick Bite: A Hidden Critter and the Power of Deeper Levels. Am J Dermatopathol 44(3):226-229, 2022. PMID: 35050559.
Alvarez P, Torres-Cabala C, Gotuzzo E, Bravo F. Cutaneous balamuthiasis: A clinicopathological study. JAAD Int 6:51-58, 2022. e-Pub 2022. PMID: 35059659.
Bartley BR, Huen A, Rady PL, Tyring SK, Nagarajan P, Aung PP, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG, Cho WC. Eosinophilic Homogeneous Intracytoplasmic Inclusion Bodies: Unique Viral Cytopathic Changes to be Associated with Epidermodysplasia Verruciformis and Human Papillomavirus Type 49. J Cutan Pathol. e-Pub 2022. PMID: 35262953.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H. T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20(3):285-308, 2022. PMID: 35276674.
Creasy CA, Meng YJ, Forget MA, Karpinets T, Tomczak K, Stewart C, Torres-Cabala CA, Pilon-Thomas S, Sarnaik AA, Mule JJ, Garraway L, Bustos M, Zhang J, Patel SP, Diab A, Glitza IC, Yee C, Tawbi H, Wong MK, McQuade J, Hoon DSB, Davies MA, Hwu P, Amaria RN, Haymaker C, Beroukhim R, Bernatchez C. Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma. Clin Cancer Res. e-Pub 2022. PMID: 35190823.
Guitart J, Chung C, Torres-Cabala CA. The dilemma of primary γδ epidermotropic T-cell lymphoma: Distinction from mycosis fungoides, signs of cytotoxicity, and need for more detailed analysis. J Cutan Pathol. e-Pub 2022. PMID: 35080039.
Mendoza R, Quiñones MP, Beltrán BE, Castro D, Paredes S, Miranda RN, Moisés C, Sánchez G, Castillo JJ, Torres-Cabala C. Primary cutaneous Epstein-Barr virus-positive B-cell lymphoid proliferation with features of diffuse large B-cell lymphoma and mucocutaneous ulcer: a diagnostic dilemma. (*Mentor of an international Pathology resident). Int J Dermatol. e-Pub 2022. PMID: 35064673.
Starling CT, Messer AA, Kleiman A, McQuade JL, Glitza IC, Torres-Cabala CA, Heberton M. Interstitial granulomatous dermatitis and concurrent immunotherapy associated encephalitis with nivolumab and ipilimumab. Dermatology Online Journal-Case Presentation 28(2), 2022.
Seervai RNH, Heberton M, Cho WC, Gill P, Murphy MB, Aung PP, Nagarajan P, Torres-Cabala CA, Patel AB, Ruiz-Bañobre J, Om A, Yamamoto T, Nikolaou V, Curry JL. Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma. J Cutan Pathol. e-Pub 2021. PMID: 34888886.
Saleh M, Javadi S, Elsherif S, Patnana M, Sagebiel TL, Torres-Cabala C, Matei J, Bhosale P, Faria SC. Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to Treatment. Radiographics 41(7):1954-1972, 2021. e-Pub 2021. PMID: 34678102.
Nguyen CN, Iyer SP, Miranda RN, Torres-Cabala CA, Curry JL, Fang P, Thomas VD, Huen AO. Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse. JAAD Case Rep 17:34-37, 2021. e-Pub 2021. PMID: 34692965.
Seervai RNH, Cho WC, Chu EY, Marques-Piubelli ML, Ledesma DA, Richards K, Heberton MM, Nelson KC, Nagarajan P, Torres-Cabala CA, Prieto VG, Curry JL. Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy. J Cutan Pathol. e-Pub 2021. PMID: 34622477.
Giubellino A*, Nelson AC, He Y, Munro SA, Song KY, Glitza Oliva IC, Torres-Cabala C. Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus-like features. (*Mentor of a junior colleague). Pigment Cell Melanoma Res. e-Pub 2021. PMID: 34633770.
Cho WC*, Gill P, Aung PP, Gu J, Nagarajan P, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. The utility of digital pathology in improving the diagnostic skills of pathology trainees in commonly encountered pigmented cutaneous lesions during the COVID-19 pandemic: A single academic institution experience. (*Mentor of a Dermatopathology Fellow). Ann Diagn Pathol 54:151807, 2021. e-Pub 2021. PMID: 34418768.
El Hussein S, Wang W, Wang SA, Loghavi S, Wang X, Qiu L, Fang H, Medeiros LJ, Aung PP, Torres Cabala C, Jorgensen JL, Pemmaraju N, Khoury JD. Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia: Illustration of morphologic and immunophenotypic challenges of an emerging phenomenon. Leuk Lymphoma:1-4. e-Pub 2021. PMID: 34304666.
Torres-Cabala CA, Huen A, Iyer SP, Miranda RN. Gamma/Delta Phenotype in Primary Cutaneous T-cell Lymphomas and Lymphoid Proliferations: Challenges for Diagnosis and Classification. Surg Pathol Clin 14(2):177-194, 2021. e-Pub 2021. PMID: 34023099.
Mehta R, Torres Cabala CA, DiNardo CD, Daver N, Dabaja B, Rezvani K, Champlin RE, Shpall E, Duvic M. Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant Hemophagocytic lymphohistiocytosis. Am J Hematol. e-Pub 2021. PMID: 34096089.
Wu C, Peng S, Pilie PG, Geng C, Park S, Manyam GC, Lu Y, Yang G, Tang Z, Kondraganti S, Wang D, Hudgens CW, Ledesma DA, Marques-Piubelli ML, Torres Cabala CA, Curry JL, Troncoso P, Corn PG, Broom BM, Thompson TC. PARP and CDK4/6 inhibitor combination therapy induces apoptosis and suppresses neuroendocrine differentiation in prostate cancer. Mol Cancer Ther. e-Pub 2021. PMID: 34158347.
Gill P*, Richards K, Cho WC, Nagarajan P, Aung PP, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Localized cutaneous argyria: Review of a rare clinical mimicker of melanocytic lesions. (*Mentor of a Dermatopathology Fellow). Ann Diagn Pathol 54:151776. e-Pub 2021. PMID: 34214703.
Gill P*, Prieto VG, Austin MT, Giubellino A, Torres-Cabala CA. Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi. (*Mentor of a Dermatopathology Fellow). J Cutan Pathol. e-Pub 2021. PMID: 34164835.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol 34(4):710-719, 2021. e-Pub 2020. PMID: 33011748.
Ronen S, Al-Rohil RN, Keiser E, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Middleton LP, Torres-Cabala CA, Gershenwald JE, Aung PP, Prieto VG. Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management. Arch Pathol Lab Med. e-Pub 2021. PMID: 33577643.
Collins K*, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? (*Mentor of a Pathology Fellow). Virchows Arch. e-Pub 2021. PMID: 33604757.
Sweeney KJ, Tetzlaff MT, Vega F, Gillenwater A, Zuo Z, Gross N, Nagarajan P, Wargo J, Nelson K, Prieto VG, Torres-Cabala CA, Curry JL. Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response. J Cutan Pathol. e-Pub 2021. PMID: 33399228.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Nagarajan P, Curry JL, Ciurea AM, Rubin AI, Hwu WJ, Prieto VG, Aung PP. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma. Arch Pathol Lab Med. e-Pub 2020. PMID: 33290520.
Duke TC, Nair R, Torres-Cabala C, Amaria RN, Keiser E, Miranda R, Iyer SP, Heberton M. Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment. JAAD Case Rep 6(12):1264-1267, 2020. e-Pub 2020. PMID: 33294560.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kim YH, Mehta-Shah N, Olsen EA, Pro B, Rajguru SA, Rozati S, Said J, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H. NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021. J Natl Compr Canc Netw 18(11):1460-1467, 2020. e-Pub 2020. PMID: 33152703.
Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma. Arch Pathol Lab Med. e-Pub 2020. PMID: 33053175.
Torres-Cabala C, Li-Ning-Tapia E, Hwu WJ. Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma. Arch Med Res. e-Pub 2020. PMID: 32950263.
Vougiouklakis T, Aung PP, Vasudevaraja V, Prieto VG, Torres-Cabala CA, Sulman EP, Snuderl M, Jour G. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors. Sci Rep 10(1):12996, 2020. e-Pub 2020. PMID: 32747660.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma. Mod Pathol. e-Pub 2020. PMID: 32759976.
Aung PP, Pemmaraju N, Torres-Cabala CA, Duvic M, Konopleva M, Khoury JD, Prieto VG. Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall. J Dermatol. e-Pub 2020. PMID: 32770556.
Ronen S*, Keiser E*, Collins KM, Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Hymes S, Medeiros LJ, Torres-Cabala CA. Langerhans cell sarcoma involving skin and showing epidermotropism: a comprehensive review (*Mentor of a Dermatopathology Fellow). J Cutan Pathol. e-Pub 2020. PMID: 32644218.
Tran J*, Duvic M, Torres-Cabala CA. Lymphomatoid Papulosis With a Unique T Follicular Helper-Like Phenotype (*Mentor of a Medical Student). Am J Dermatopathol. e-Pub 2020. PMID: 32568843.
Hong BY, Ford JR, Glitza IC, Torres Cabala CA, Tetzlaff M, Prieto VG, Parker R, Daniel C, Esmaeli B. Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma. Ophthalmic Plast Reconstr Surg. e-Pub 2020. PMID: 32618825.
Kwon D*, Ronen S, Giubellino A, Keiser E, Aung PP, Nagarajan P, Tetzlaff MT, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Cutaneous Adnexal Carcinosarcoma: Immunohistochemical and Molecular Evidence of Epithelial Mesenchymal Transition (*Mentor of a Pathology Fellow). J Cutan Pathol. e-Pub 2020. PMID: 32564423.
Chen PL*, Neishaboori N, Tetzlaff MT, Chen WS, Aung PP, Curry JL, Nagarajan P, Ivan D, Hwu WJ, Prieto VG, Torres-Cabala CA. BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma (*Mentoring of a Dermatopathology Fellow). Am J Dermatopathol 42(5):313-321, 2020. PMID: 32310893.
Ramachandran V, Park KE, Torres-Cabala CA, Duvic M. Second primary malignancies in subcutaneous panniculitis-like T-cell lymphoma: a national database study. Clin Exp Dermatol. e-Pub 2020. PMID: 32359183.
Marques-Piubelli ML, Tetzlaff MT, Nagarajan P, Duke TC, Glitza Oliva IC, Ledesma DA, Aung PP, Torres-Cabala CA, Wistuba II, Prieto VG, Nelson KC, Curry JL. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma. J Cutan Pathol. e-Pub 2020. PMID: 32394425.
Ramani NS*, Aung PP, Gu J, Sfamenos S, Sdringola-Maranga C, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Diab A, Prieto VG, Hwu WJ, Torres-Cabala CA. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis (*Mentoring of a Pathology Fellow). Mod Pathol. e-Pub 2020. PMID: 32404956.
Mehta-Shah N, Horwitz SM, Anseli S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Fisher K, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Lunning MA, Mehta A, Olsend EA, Pro B, Raiguru SA, Shanbhag S, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala CA, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H, Kim YH. NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020. Journal of the National Comprehensive Cancer Network 18(5):522-536, 2020.
Farah M, Reuben A, Spassova I, Yang RK, Kubat L, Nagarajan P, Ning J, Li W, Aung PP, Curry JL, Torres-Cabala CA, Hudgens CW, Ugurel S, Schadendorf D, Gumbs C, Little LD, Futreal A, Wistuba II, Prieto VG, Wang L, Wong MK, Wargo JA, Becker JC, Tetzlaff MT. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma. J Invest Dermatol. e-Pub 2020. PMID: 32304704.
Farah M, Nelson KC, Tetzlaff MT, Nagarajan P, Torres-Cabala CA , Prieto VG, Curry JL, Aung PP. Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report. J Cutan Pathol, 2020.
Castaneda CA, Castillo M, Aliaga K, Bernabe LA, Casavilca S, Sanchez J, Torres-Cabala CA, Gomez HL, Mas L, Dunstan J, Cotrina JM, Abugattas J, Chavez I, Ruiz E, Montenegro P, Rojas V, Orrego E, Galvez-Nino M, Felix B, Landa-Baella MP, Vidaurre T, Villa MR, Zevallos R, Taxa L, Guerra H. Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies. Biomark Med 13(17):1481-1491, 2019. e-Pub 2019. PMID: 31621387.
Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. Cancers (Basel) 11(12), 2019. e-Pub 2019. PMID: 31888295.
Mejbel HA, Arudra SKC, Pradhan D, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Duose DY, Luthra R, Prieto VG, Ballester LY, Aung PP. Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity. Cancers (Basel) 11(11), 2019. e-Pub 2019. PMID: 31684113.
Torres-Cabala CA. Diagnosis of T-cell lymphoid proliferations of the skin: putting all the pieces together. Mod Pathol. e-Pub 2019. PMID: 31664155.
Namikawa K, Aung PP, Milton DR, Tetzlaff MT, Torres Cabala CA, Curry JL, Nagarajan P, Ivan D, Ross MI, Gershenwald JE, Prieto VG. Correlation of tumor burden in sentinel lymph nodes with tumor burden in non-sentinel lymph nodes and survival in cutaneous melanoma. Clin Cancer Res. e-Pub 2019. PMID: 31570567.
Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol. e-Pub 2019. PMID: 31383963.
Yildiz P, Aung PP, Milton DR, Hruska C, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala C, Prieto VG. Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data?. Am J Dermatopathol. e-Pub 2019. PMID: 31464719.
Ruiz SJ, Al Salihi S, Prieto VG, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Aung PP. Unusual cutaneous metastatic carcinoma. Ann Diagn Pathol 43:151399. e-Pub 2019. PMID: 31675677.
Mejbel HA, Nelson KC, Pradhan D, Ivan D, Zaleski M, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literature. J Cutan Pathol. e-Pub 2019. PMID: 31361351.
Tetzlaff MT, Tang S, Duke T, Grabell DA, Cabanillas ME, Zuo Z, Yao JC, Nagarajan P, Aung PP, Torres-Cabala CA, Duvic M, Prieto VG, Huen A, Curry JL. Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features. J Cutan Pathol. e-Pub 2019. PMID: 31254410.
Aung PP, Sukswai N, Nejati R, Loghavi S, Chen W, Torres-Cabala CA, Yin CC, Konopleva M, Zheng X, Wang J, Tang Z, Medeiros LJ, Prieto VG, Pemmaraju N, Khoury JD. PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel) 11(5), 2019. e-Pub 2019. PMID: 31109153.
Mauzo SH, Tetzlaff MT, Milton DR, Siroy AE, Nagarajan P, Torres-Cabala CA, Ivan D, Curry JL, Hudgens CW, Wargo JA, Sahin AA, Pettaway CA, Prieto VG, Aung PP. Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. Cancers (Basel) 11(6), 2019. e-Pub 2019. PMID: 31146499.
Aung PP*, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series *Mentor of a junior colleague. Am J Dermatopathol 41(3):167-179, 2019. PMID: 30801340.
Ibarra BS, Huen A, Nagarajan P, Torres-Cabala CA, Prieto VG, Aung PP. From mycosis fungoides to herpetic folliculitis: The significance of deeper H&E tissue sections in dermatopathology. J Cutan Pathol. e-Pub 2019. PMID: 30883857.
Curry JL, Reuben A, Szczepaniak-Sloane R, Ning J, Milton DR, Lee CH, Hudgens C, George S, Torres-Cabala CA, Johnson D, Subramanya S, Wargo JA, Mudaliar K, Wistuba II, Prieto VG, Diab A, Tetzlaff MT. Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response. J Cutan Pathol. e-Pub 2019. PMID: 30883858.
Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres Cabala CA, Efstathiou E, Hoang A, Wong MKK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba II, Tetzlaff MT. B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density. Clin Cancer Res. e-Pub 2019. PMID: 30808776.
Castaneda CA*, Castillo M, Torres-Cabala CA, Bernabe LA, Casavilca S, Villegas V, Sanchez J, de la Cruz M, Dunstan J, Cotrina JM, Gomez HL, Chavez C, Landa-Baella MP, Tello K, Felix BF, Abugattas J. Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma *Pathology mentor of an international working group. Clin Transl Oncol. e-Pub 2019. PMID: 30778854.
Fedda F, Migden MR, Curry JL, Torres-Cabala CA, Tetzlaff MT, Aung PP, Prieto VG, Ivan D, Myers JN, Nagarajan P. Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spread. J Cutan Pathol 46(2):152-158, 2019. e-Pub 2018. PMID: 30414196.
Trinidad CM, Torres-Cabala CA, Prieto VG, Aung PP. Update on eighth edition American Joint Committee on Cancer classification for Merkel cell carcinoma and histopathological parameters that determine prognosis. J Clin Pathol. e-Pub 2019. PMID: 30636696.
McQuade JL*, Homsi J, Torres-Cabala CA, Bassett R, Popuri RM, James ML, Vence LM, Hwu WJ. A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma *Pathology support of immune-oncology working group. BMC Cancer 18(1):1274, 2018. e-Pub 2018. PMID: 30567529.
Kim EJ, Aria AB, Wilmas K, Lewis DJ, Torres-Cabala CA, Nunez C, Dabaja BS, Duvic M. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation. Pediatr Dermatol. e-Pub 2018. PMID: 30548331.
Trinidad CM, Torres-Cabala CA, Curry JL, Prieto VG, Aung PP. Update on eighth edition American Joint Committee on Cancer classification for cutaneous melanoma and overview of potential pitfalls in histological examination of staging parameters. J Clin Pathol. e-Pub 2018. PMID: 30275100.
Jour G, Vasudevaraja V, Prieto VG, Snuderl M, Torres-Cabala CA, Al-Rohil R, Sulman EP, Ballester LY, Aung PP. BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor. Mod Pathol. e-Pub 2018. PMID: 30310175.
Konopinski JC, Danialan R, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Prieto VG, Aung PP. Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma. Hum Pathol. e-Pub 2018. PMID: 30359637.
Chen WS, Tetzlaff MT, Diwan H, Jahan-Tigh R, Diab A, Nelson K, Glitza IC, Kaunitz GJ, Johnson D, Torres-Cabala C, Pacha O, Taube JM, Maloney K, Prieto VG, Curry JL. Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions. J Cutan Pathol 45(10):764-773, 2018. e-Pub 2018. PMID: 29943453.
Ronen S, Ivan D, Torres-Cabala CA, Curry JL, Tetzlaff MT, Aung PP, Nagarajan P, Suster S, Prieto VG. Post-radiation vascular lesions of the breast. J Cutan Pathol. e-Pub 2018. PMID: 30251277.
Farah M, Nagarajan P, Curry JL, Tang Z, Kim TB, Aung PP, Torres-Cabala CA, Eterovic AK, Wargo JA, Prieto VG, Tetzlaff MT. Spitzoid melanoma with histopathologic features of ALK gene rearrangement exhibiting ALK copy number gain: A novel mechanism of ALK activation in spitzoid neoplasia. Br J Dermatol. e-Pub 2018. PMID: 29897634.
Forget MA*, Haymaker C, Hess KR, Meng YJ, Creasy C, Karpinets TV, Fulbright OJ, Roszik J, Woodman SE, Kim YU, Sakellariou-Thompson D, Bhatta A, Wahl A, Flores E, Thorsen ST, Tavera RJ, Ramachandran R, Gonzalez AM, Toth C, Wardell S, Mansaray R, Patel V, Carpio DJ, Vaughn CS, Farinas CM, Velasquez PG, Hwu WJ, Patel SP, Davies MA, Diab A, Glitza IC, Tawbi H, Wong MKK, Cain S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Wargo JA, Radvanyi LG, Torres Cabala CA, Beroukhim R, Hwu P, Amaria RN, Bernatchez C. Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome *Pathology support of a multi-department working groups. Clin Cancer Res. e-Pub 2018. PMID: 29848573.
Buchely N, Al-Rohil RN, Aung PP, Jour G, Torres-Cabala C, Prieto VG, Ivan D. Dermal xanthomatous infiltrates after brentuximab vedotin therapy in mycosis fungoides with large-cell transformation: A novel histologic finding. J Cutan Pathol. e-Pub 2018. PMID: 29806104.
Dolkar T, Trinidad CM, Nelson KC, Amaria RN, Nagarajan P, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Curry JL, Aung PP. Dermatologic Toxicity from Novel Therapy using Antimicrobial Peptide LL-37 in Melanoma: A Detailed Examination of the Clinicopathologic Features. J Cutan Pathol. e-Pub 2018. PMID: 29665030.
Trinidad C, Nelson KC, Glitza Oliva IC, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Ivan D, Hwu WJ, Prieto VG, Curry JL, Aung PP. Dermatologic Toxicity from Immune Checkpoint Blockade Therapy with an Interstitial Granulomatous Pattern. J Cutan Pathol. e-Pub 2018. PMID: 29633300.
Farah M, Nagarajan P, Torres-Cabala CA, Curry JL, Amaria RN, Wargo J, Tawbi H, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfall. J Cutan Pathol. e-Pub 2018. PMID: 29672900.
Mauzo SH, Milton DR, Prieto VG, Torres-Cabala CA, Wang WL, Chakravarti N, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Brown RE, Aung PP. Summary of Expression of SPARC Protein in Cutaneous Vascular Neoplasms and Mimickers. Ann Diagn Pathol 34:151-154. e-Pub 2018. PMID: 29660567.
Al-Rohil RN, Milton DR, Nagarajan P, Curry JL, Feldmeyer L, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Intratumoral and Peritumoral Lymphovascular Invasion Detected by D2-40 Immunohistochemistry Correlates with Metastasis in Primary Cutaneous Merkel Cell Carcinoma. Hum Pathol. e-Pub 2018. PMID: 29601841.
Tetzlaff MT, Nelson KC, Diab A, Staerkel GA, Nagarajan P, Torres-Cabala CA, Chasen BA, Wargo JA, Prieto VG, Amaria RN, Curry JL. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. J Immunother Cancer 6(1):14, 2018. e-Pub 2018. PMID: 29433571.
Lewis DJ, Miranda RN, Oh CW, Hinojosa T, Medeiros LJ, Curry JL, Tetzlaff MT, Torres-Cabala CA, Nagarajan P, Ravandi-Kashani F, Duvic M. Pruritic arthropod bite-like papules in T-cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia. Clin Exp Dermatol. e-Pub 2018. PMID: 29423961.
Aria AB*, Chen L, Torres-Cabala CA, Chon SY. Chronic granulomatous reaction in patients receiving vaccine immunotherapy for metastatic melanoma * Pathology mentor of a medical student. JAAD Case Rep 4(1):87-90, 2018. e-Pub 2017. PMID: 29379857.
Wilmas K, Aria A, Torres-Cabala CA, Lu H, Duvic M. Schnitzler syndrome in a patient with a family history of monoclonal gammopathy *Pathology mentor of a medical student. Dermatol Online J 24(1), 2018. e-Pub 2018. PMID: 29469761.
Mauzo SH, Tetzlaff MT, Nelson K, Amaria R, Patel S, Aung PP, Nagarajan P, Torres-Cabala CA, Diab A, Prieto VG, Curry JL. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. Int J Dermatol. e-Pub 2017. PMID: 29152725.
Beltran BE, Quiñones P, Sanchez G, Paredes A, Moises C, Cotrina E, Torres-Cabala CA, Miranda RN, Castillo JJ. Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?. Leuk Lymphoma:1-3. e-Pub 2017. PMID: 29081245.
Horna P*, Shao H, Idrees A, Glass LF, Torres-Cabala CA. Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature *Mentor of a junior colleague. J Cutan Pathol. e-Pub 2017. PMID: 28880462.
Loghavi S, Curry JL, Garcia-Manero G, Patel KP, Xu J, Khoury JD, Torres-Cabala CA, Nagarajan P, Aung PP, Gibson BR, Goodwin BP, Kelly BC, Korivi BR, Medeiros LJ, Prieto VG, Kantarjian HM, Bueso-Ramos CE, Tetzlaff MT. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia. J Cutan Pathol. e-Pub 2017. PMID: 28885734.
Tetzlaff MT, Jazaeri AA, Torres-Cabala CA, Korivi BR, Landon GA, Nagarajan P, Choksi A, Chen L, Uemura M, Aung PP, Diab A, Sharma P, Davies MA, Amaria R, Prieto VG, Curry JL. Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients. J Cutan Pathol. e-Pub 2017. PMID: 28901560.
Jour G*, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CA. Differential expression of CCR4 in primary cutaneous gamma/delta (γ/δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy *Mentor of a Dermatopathology Fellow. Awardee of Pathology Chair's Mentored Fellow Award. J Dermatol Sci. e-Pub 2017. PMID: 29030090.
Saenz-Ibarra B, Prieto VG, Torres-Cabala CA, Huen A, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Coccidioidomycosis Involving Lungs and Skin: A Mimicker of Metastatic Disease. Am J Dermatopathol. e-Pub 2017. PMID: 28857979.
Valero-Torres A, Prieto VG, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall. Am J Dermatopathol 39(6):468-470, 2017. PMID: 28525424.
Castaneda CA*, Torres-Cabala C, Castillo M, Villegas V, Casavilca S, Cano L, Sanchez J, Dunstan J, Calderon G, De La Cruz M, Cotrina JM, Gomez HL, Galvez R, Abugattas J. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America *Pathology Mentor of an international working group. Clin Transl Oncol. e-Pub 2017. PMID: 28577153.
Ramani N*, Aung PP, Hwu WJ, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Torres-Cabala CA. Aberrant Expression of FLI-1 in Melanoma *Mentor of a Pathology Resident. J Cutan Pathol. e-Pub 2017. PMID: 28605142.
Chakravarti N, Ivan D, Trinh VA, Glitza IC, Curry JL, Torres-Cabala C, Tetzlaff MT, Bassett RL, Prieto VG, Hwu WJ. High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients. Melanoma Res 27(1):24-31, 2017. PMID: 27768639.
Tetzlaff MT, Nagarajan P, Chon S, Huen A, Diab A, Omar P, Aung PP, Torres-Cabala CA, Mays SR, Prieto VG, Curry JL. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. Am J Dermatopathol 39(2):121-129, 2017. PMID: 28134729.
Shustef E*, Torres-Cabala CA, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Aung PP. Intraepithelial Melanoma in the Stomach After Treatment With Immune Checkpoint Blockade Therapy *Co-mentor of a Dermatopathology Fellow. Am J Dermatopathol. e-Pub 2017. PMID: 28248716.
Agbay RL*, Torres-Cabala CA, Patel KP, Merril ED, Duvic M, Quesada A, Prieto VG, Aung PP, Loghavi S, Young KH, Hu S, Ferrufino-Schmidt MC, Tetzlaff M, Li S, Medeiros LJ, Miranda RN. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens *Co-mentor of an international visiting Pathology Fellow. Am J Surg Pathol. e-Pub 2017. PMID: 28248813.
Nicolae A, Ganapathi KA, Pham TH, Xi L, Torres-Cabala CA, Nanaji NM, Zha HD, Fan Z, Irwin S, Pittaluga S, Raffeld M, Jaffe ES. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features. Am J Surg Pathol 41(1):67-74, 2017. PMID: 27631517.
Konopinski J, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PP. Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor. Am J Dermatopathol. e-Pub 2017. PMID: 28178009.
Alberti-Violetti S*, Torres-Cabala CA, Talpur R, Corti L, Fanoni D, Venegoni L, Berti E, Duvic M. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma *Pathology mentor of an international visiting Dermatology Fellow. J Cutan Pathol 43(12):1121-1130, 2016. e-Pub 2016. PMID: 27550169.
Curry JL, Tetzlaff MT, Nagarajan P, Drucker C, Diab A, Hymes SR, Duvic M, Hwu WJ, Wargo JA, Torres-Cabala CA, Rapini RP, Prieto VG. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol. e-Pub 2016. PMID: 27859479.
Nagarajan P, Curry JL, Ning J, Piao J, Torres Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto V, Tetzlaff MT. Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: A retrospective review of 100 cases. Clin Cancer Res. e-Pub 2016. PMID: 27864417.
Merrill ED*, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas *Mentor of a medical student. Am J Surg Pathol. e-Pub 2016. PMID: 27879514.
Pina-Oviedo S, Torres-Cabala CA, Miranda RN, Tetzlaff MT, Singh S, Rapini RP, Prieto VG, Aung PP. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis. Am J Dermatopathol. e-Pub 2016. PMID: 27759701.
Aung PP*, Rady PL, Nagarajan P, Ivan D, Tetzlaff MT, Curry JL, Tyring SK, Prieto VG, Torres-Cabala CA. Detection of Merkel Cell Polyoma Virus and Beta Human Papillomavirus in Multiple Eccrine Poromas in a Patient With Acute Leukemia Treated With Stem Cell Transplant *Mentor of a junior colleague. Am J Dermatopathol. e-Pub 2016. PMID: 27655121.
Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG. Clinical Significance of BRAF V600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma. Hum Pathol. e-Pub 2016. PMID: 27666765.
Honarpisheh HH, Curry JL, Richards K, Nagarajan P, Aung PP, Torres-Cabala CA, Ivan D, Drucker CR, Cartun R, Prieto VG, Tetzlaff MT. Cutaneous histoplasmosis with prominent parasitization of epidermal keratinocytes: Report of a case. J Cutan Pathol. e-Pub 2016. PMID: 27516534.
Al-Rohil RN*, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, Curry JL, Miranda RN, Duvic M, Prieto VG, Aung PP. Loss of CD30 expression after treatment with Brentuximab Vedotin in a patient with Anaplastic Large Cell Lymphoma: a novel finding *Co-mentor of a Dermatopathology Fellow. J Cutan Pathol. e-Pub 2016. PMID: 27531242.
Ramani NS *, Curry JL, Merrill ED, Aung PP, Prieto V, Tetzlaff MT, Duvic M, Miranda R, Torres-Cabala C. Primary Cutaneous Gamma-Delta (γ/δ) T-cell Lymphoma: An Unusual Case With Very Subtle Histopathological Findings *Mentor of a Pathology resident. Am J Dermatopathol. e-Pub 2016. PMID: 27533072.
Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M. Primary cutaneous CD30(+) lymphoproliferative disorders. J Dtsch Dermatol Ges 14(8):767-82, 2016. PMID: 27509411.
Mauzo SH, Ferrarotto R, Bell D, Torres-Cabala CA, Tetzlaff MT, Prieto VG, Aung PP. Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma. J Clin Pathol 69(5):382-90, 2016. e-Pub 2016. PMID: 26818033.
Feldmeyer L, Hudgens CW, Lyons GR, Nagarajan P, Aung PP, Curry JL, Torres Cabala CA, Mino B, Rodriguez-Canales J, Reuben A, Chen PL, Ko JS, Billings SD, Bassett RL, Wistuba II, Cooper ZA, Prieto VG, Wargo JA, Tetzlaff MT. Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma. Clin Cancer Res. e-Pub 2016. PMID: 27166398.
Mudaliar K, Tetzlaff MT, Duvic M, Ciurea A, Hymes S, Milton DR, Tsai KY, Prieto VG, Torres-Cabala CA, Curry JL. BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Hum Pathol 50:79-89, 2016. e-Pub 2015. PMID: 26997441.
Jour G, Glitza IC, Ellis RM, Torres-Cabala CA, Tetzlaff MT, Li JY, Nagarajan P, Huen A, Aung PP, Ivan D, Drucker CR, Prieto VG, Rapini RP, Patel A, Curry JL. Autoimmune Dermatologic Toxicities from Immune Checkpoint Blockade with anti-PD-1 Antibody Therapy: A Report on Bullous Skin Eruptions. J Cutan Pathol. e-Pub 2016. PMID: 27086658.
Ravishankar S, Nagarajan P, Curry JL, Tetzlaff MT, Ivan D, Torres-Cabala CA, Aung PP, Prieto VG. Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas. J Cutan Pathol. e-Pub 2016. PMID: 27124588.
Feldmeyer L, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Bell D, Moon BS, Torres-Cabala CA, Aung PP. Role of Radiotherapy in Aggressive Digital Papillary Adenocarcinoma. Ann Clin Lab Sci 46(2):222-4, 2016. PMID: 27098633.
Al-Rohil RN, Curry JL, Torres-Cabala CA, Nagarajan P, Ivan D, Aung PP, Ray GF, Bassett RL, Prieto VG, Tetzlaff MT. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Hum Pathol. e-Pub 2016. PMID: 27004944.
Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, Xu C, McKenzie JA, Zhang C, Liang X, Williams LJ, Deng W, Chen G, Mbofung R, Lazar AJ, Torres Cabala CA, Cooper ZA, Chen PL, Tieu TN, Spranger S, Yu X, Bernatchez C, Forget MA, Haymaker C, Amaria R, McQuade JL, Glitza IC, Cascone T, Li H, Kwong LN, Heffernan TP, Hu J, Bassett RL, Bosenberg MW, Woodman SE, Overwijk WW, Lizee G, Roszik J, Gajewski TF, Wargo JA, Gershenwald JE, Radvanyi LG, Davies MA, Hwu P. Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov. e-Pub 2015. PMID: 26645196.
Feldmeyer L, Tetzlaff M, Fox P, Nagarajan P, Curry J, Ivan D, Torres Cabala CA, Prieto VG, Aung PP. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma. Am J Dermatopathol. e-Pub 2015. PMID: 26675354.
Danialan R, Tetzlaff MT, Torres-Cabala CA, Mays SR, Prieto VG, Bell D, Curry JL. Cutaneous metastasis from anaplastic thyroid carcinoma exhibiting exclusively a spindle cell morphology. A case report and review of literature. J Cutan Pathol. e-Pub 2015. PMID: 26347145.
Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL. Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma. Hum Pathol 46(8):1101-10, 2015. e-Pub 2015. PMID: 26058727.
Ramani NS*, Curry JL, Kapil J, Rapini RP, Tetzlaff MT, Prieto VG, Torres-Cabala CA. Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma *Mentor of a Pathology resident. Am J Dermatopathol 37(8):e96-9, 2015. PMID: 25839886.
Oh CW*, Ivan D, Curry JL, Ellis R, Gerber H, Duvic M, Torres-Cabala C. A case of indeterminate dendritic cell tumor presenting with leonine facies *Mentor of an international visitor dermatologist. J Cutan Pathol. e-Pub 2015. PMID: 26272726.
Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT. Use of Clinical Next-Generation Sequencing To Identify Melanomas Harboring SMARCB1 Mutations. J Cutan Pathol. e-Pub 2015. PMID: 25754356.
Torres-Cabala CA, Curry JL, Li Ning Tapia EM, Ramos C, Tetzlaff MT, Prieto VG, Miranda RN, Bravo F. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci. e-Pub 2015. PMID: 25676425.
Wang WL, Torres-Cabala C, Curry J, Ivan D, McLemore M, Tetzlaff M, Zembowicz A, Prieto VG, Lazar AJ. Metastatic Atypical Fibroxanthoma: A Series of 11 Cases Including With Minimal and No Subcutaneous Involvement. Am J Dermatopathol. e-Pub 2015. PMID: 25590287.
Tetzlaff MT,Torres-Cabala CA, Pattanaprichakul P, Rapini RP, Prieto VG, Curry JL. Emerging clinical applications of selected biomarkers in melanoma. Clin Cosmet Investig Dermatol 8:35-46. e-Pub 2015. PMID: 25674009.
de la Garza Bravo MM, Patel KP, Loghavi S, Curry JL, Torres Cabala CA, Cason RC, Gangar P, Prieto VG, Medeiros LJ, Duvic M, Tetzlaff MT. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. Hum Pathol. e-Pub 2014. PMID: 25666664.
Loghavi S, Curry JL, Torres-Cabala CA, Ivan D, Patel KP, Mehrotra M, Bassett R, Prieto VG, Tetzlaff MT. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature. Mod Pathol 27(11):1468-78, 2014. e-Pub 2014. PMID: 24743221.
Beltrán BE*, Castillo JJ, Quiñones P, Morales D, Paredes A, Nieto G, Miranda RN, Torres-Cabala CA. Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvement *Mentor of an international junior colleague. Am J Dermatopathol 36(11):e189-93, 2014. PMID: 25238445.
Henderson SA, Tetzlaff MT, Pattanaprichakul P, Fox P, Torres-Cabala CA, Bassett RL, Prieto VG, Richards HW, Curry JL. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma. J Cutan Pathol. e-Pub 2014. PMID: 25263506.
Henderson SA*, Torres-Cabala CA, Curry JL, Bassett RL, Ivan D, Prieto VG, Tetzlaff MT. p40 Is More Specific Than p63 for the Distinction of Atypical Fibroxanthoma From Other Cutaneous Spindle Cell Malignancies *Co-mentor of a Dermatopathology Fellow. Am J Surg Pathol 38(8):1102-10, 2014. PMID: 25029117.
Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL,Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF(V600): Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma. J Invest Dermatol. e-Pub 2014. PMID: 25148578.
Kim CY, Kim DW, Kim K, Curry J, Torres-Cabala C, Patel S. GNAQ mutation in a patient with metastatic mucosal melanoma. BMC Cancer 14(1):516. e-Pub 2014. PMID: 25030020.
Curry JL, Tetzlaff MT, Nicholson K, Duvic M, Kim KB, Tsai KY, Hwu WJ, Hong DS, Prieto VG, Torres-Cabala CA. Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy *Co-PI of a large series of cases from our institution. Am J Dermatopathol 36(7):557-61, 2014. PMID: 24950418.
De la Garza Bravo MM, Curry JL, Torres-Cabala CA, Ivan DS, Drucker C, Prieto VG, Tetzlaff MT. Pigmented extramammary Paget disease of the thigh mimicking a melanocytic tumor: report of a case and review of the literature. J Cutan Pathol 41(6):529-35, 2014. e-Pub 2014. PMID: 24698435.
Pattanaprichakul P, Tetzlaff MT, Lapolla WJ, Torres-Cabala CA, Duvic M, Prieto VG, Tsai KY, Curry JL. Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma. J Cutan Pathol 41(3):326-8, 2014. e-Pub 2013. PMID: 24372055.
Curry JL,Torres-Cabala CA, Kim KB, Tetzlaff MT, Duvic M, Tsai KY, Hong DS, Prieto VG. Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions. Int J Dermatol 53(3):376-84, 2014. e-Pub 2013. PMID: 23879247.
McQuitty E*, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala C. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis *Mentor of a Pathology resident. First place among oral presentations at the American Society of Dermatopathology meeting, 2012. J Cutan Pathol 41(2):88-100, 2014. e-Pub 2013. PMID: 24118002.
Buonaccorsi JN, Prieto VG, Torres-Cabala C, Suster S, Plaza JA. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases. American Journal of Dermatopathology 36(2):124-30, 2014. PMID: 23782678.
Wright NA*, Torres-Cabala CA, Curry JL, Cutlan JE, Hymes SR. Post-varicella-zoster virus granulomatous dermatitis: a report of 2 cases *Pathology mentor of a medical student. Cutis 93(1):50-4, 2014. PMID: 24505586.
Chavan RN, Bridges AG, Knudson RA, Ketterling RP, Comfere N, Wada DA, Torres-Cabala C, DiCaudo DJ, Vasmatzis G, Pittelkow MR, Feldman AL. Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course. Blood Cancer J 4:e253, 2014. e-Pub 2014. PMID: 25325303.
Aung PP*, Climent F, Muzzafar T, Curry JL, Patel KP, Servitje O, Prieto VG, Duvic M, Jaffe ES, Torres-Cabala CA. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases *Mentor of a junior colleague. J Cutan Pathol 41(1):51-7, 2014. e-Pub 2013. PMID: 24151865.
Tetzlaff MT, Wang WL, Milless TL, Curry JL, Torres-Cabala CA, McLemore MS, Ivan D, Bassett RL, Prieto VG. Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses. Am J Surg Pathol 37(12):1783-96, 2013. PMID: 24061523.
Le Loarer F, Barete S, Vallat L, Carre D, El Amarti R, Torres-Cabala C, Cacoub P, Sene D, Courville P, Bravard P. Primary cutaneous CD8+ T-cell lymphoma masquerading as acral vascular syndrome. Acta Derm Venereol. e-Pub 2013. PMID: 23995595.
Curry JL, Falchook GS, Hwu WJ, Torres-Cabala CA, Duvic M, Tetzlaff MT, Prieto VG. Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor. Am J Dermatopathol 35(1):125-8, 2013. PMID: 22878367.
Tetzlaff MT, Curry JL, Ivan D, Wang WL, Torres-Cabala CA, Bassett RL, Valencia KM, McLemore MS, Ross MI, Prieto VG. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Mod Pathol 9:1153-1160, 2013. e-Pub 2013. PMID: 23558574.
Nava VE, Torres-Cabala C. Novel Intra-Adrenal Secondary Lymphoid Follicle Formation. Endocr Pathol 24(4):248-249, 2013. PMID: 24014039.
Chu VH, Tetzlaff MT,Torres-Cabala CA, Prieto VG, Bassett R, Gershenwald JE, McLemore MS, Ivan D, Wang WL, Ross MI, Curry JL. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas. Biomed Res Int 2013:898719, 2013. e-Pub 2013. PMID: 24369020.
Curry CV, Konoplev SN, Torres-Cabala C, Alousi A, Duvic M, Curry JL. Blastic Plasmacytoid Dendritic Cell Neoplasm with Leukemic Progress. J Med Cases 3(6):337-339, 2012.
Curry JL, Torres-Cabala CA, Tetzlaff MT, Bowman C, Prieto VG. Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma. Semin Cutan Med Surg 31(4):267-73, 2012. PMID: 23174497.
Curry JL, Torres-Cabala CA, Warneke CL, Zhang P, Prieto VG. Distinct Subcellular Localization of GSK-3β in Melanocytic Nevi: Implications in Melanocyte Senescence. OJ Pathology 2:113-119, 2012. e-Pub 2012.
Rose CL, Chakravarti N, Curry JL, Torres-Cabala CA, Bassett R, Prieto VG, Tetzlaff MT. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms. J Cutan Pathol 39(8):762-8, 2012. e-Pub 2012. PMID: 22764884.
Zhang YH, Wang WL, Rapini RP, Torres-Cabala C, Prieto VG, Curry JL. Syringocystadenocarcinoma Papilliferum With Transition to Areas of Squamous Differentiation: A Case Report and Review of the Literature. American Journal of Dermatopathology 34(4):428-33, 2012. e-Pub 2012. PMID: 22343110.
Shirley SH, Greene VR, Duncan LM, Torres Cabala CA, Grimm EA, Kusewitt DF. Slug Expression during Melanoma Progression. Am J Pathol 180(6):2479-89, 2012. e-Pub 2012. PMID: 22503751.
McLemore MS*, Bruner JM, Curry JL, Prieto VG, Torres-Cabala CA. Anaplastic oligodendroglioma involving the subcutaneous tissue of the scalp: report of an exceptional case and review of the literature *Mentor of a junior colleague. Am J Dermatopathol 34(2):214-9, 2012. e-Pub 2011. PMID: 22157246.
Martinez DR, Richards HW, Lin Q, Torres-Cabala CA, Prieto VG, Curry JL, Medrano EE. H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma. J Skin Cancer 2012:823534, 2012. e-Pub 2012. PMID: 23227340.
Béjar C*, Vidarte G, Chian C, Valencia J,Torres-Cabala C. Nodular syphilis spread associated with HIV/AIDS prozone phenomenon *Mentor of an international Dermatology resident. Dermatol Peru 23(3):162-165, 2012.
Williams VL*, Torres-Cabala CA, Duvic M. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: A retrospective case series and review of the provisional cutaneous lymphoma category *Pathology mentor of a medical student. Am J Clin Dermatol 12(6):389-401, 2011. PMID: 21863906.
McLemore MS, Huo L, Deavers MT, Curry JL, Torres-Cabala CA, Wang WL, Prieto VG. Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall. J Cutan Pathol 38(10):818-22, 2011. e-Pub 2011. PMID: 21752053.
Savar A, Oellers P, Myers J, Prieto VG, Torres-Cabala C, Frank SJ, Ivan D, Esmaeli B. Positive Sentinel Node in Sebaceous Carcinoma of the Eyelid. Ophthal Plast Reconstr Surg 27(1):e4-6, 2011. e-Pub 2010. PMID: 20940661.
Diamantis ML, Richmond HM, Rady PL, Tyring SK, Cutlan JE, Torres-Cabala C, Hymes SR. Detection of human papillomavirus in multiple eccrine poromas in a patient with chronic graft-vs-host disease and immunosuppression. Arch Dermatol 147(1):120-2, 2011. PMID: 21242407.
Rashid RM, Torres-Cabala C, Chon S. Longitudinal erythronychia: the value of cosmetic alterations in nail findings. Skinmed 9(1):60-1, 2011. PMID: 21409965.
Torres-Cabala CA, Plaza JA, Diwan AH, Prieto VG. Severe architectural disorder is a potential pitfall in the diagnosis of small melanocytic lesions. J Cutan Pathol 37(8):860-5, 2010. e-Pub 2009. PMID: 19614731.
Plaza JA, Torres-Cabala C, Evans H, Diwan HA, Suster S, Prieto VG. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum. Am J Dermatopathol 32(2):129-36, 2010. PMID: 20010406.
Geddes ER, Polder K, Cutlan JE, Torres-Cabala CA, Hymes SR. Ulcerated plaque under a ruby ring in an immunosuppressed patient. Dermatol Online J 16(8):4, 2010. e-Pub 2010. PMID: 20804681.
Cutlan JE, Rashid RM, Torres-Cabala C, Tyring SK, Thomas V. Epidermodysplasia verruciformis after cutaneous T-cell lymphoma: Periungual presentation. Dermatol Online J 16(8):12, 2010. e-Pub 2010. PMID: 20804689.
Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 22(11):1446-56, 2009. e-Pub 2009. PMID: 19718013.
Plaza JA, Torres-Cabala C, Ivan D, Prieto VG. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy. J Cutan Pathol 36(7):729-33, 2009. PMID: 19519604.
Plaza JA, Torres-Cabala C, Evans H, Diwan AH, Prieto VG. Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases. Am J Dermatopathol 31(5):419-22, 2009. PMID: 19542912.
Shanti RM, Torres-Cabala CA, Jaffe ES, Wilson WH, Brahim JS. Lymphomatoid granulomatosis with involvement of the hard palate: a case report. J Oral Maxillofac Surg 66(10):2161-3, 2008. PMID: 18848119.
Merino MJ, Torres-Cabala C, Pinto P, Linehan WM. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31(10):1578-85, 2007. PMID: 17895761.
Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177(6):2074-9, 2007. PMID: 17509289.
Schinstine M, Filie AC, Torres-Cabala C, Abati A, Linehan WM, Merino M. Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: report of a case and review of the literature. Diagn Cytopathol 34(11):751-6, 2006. PMID: 17121198.
Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ. Proteomic identification of new biomarkers and application in thyroid cytology. Acta Cytol 50(5):518-528, 2006. PMID: 17017437.
Schinstine M, Torres-Cabala C, Brosky K, Roth MJ. Ganglion cyst in a 52-year-old man with metastatic melanoma. Diagn Cytopathol 34(7):485, 2006. PMID: 16783777.
Kim CM, Vocke C, Torres-Cabala C, Yang Y, Schmidt L, Walther M, Linehan WM. Expression of hypoxia inducible factor-lalpha and 2alpha in genetically distinct early renal cortical tumors. J Urol 175(5):1908-14, 2006. PMID: 16600797.
Li-Ning-T E, Ronchetti R, Torres-Cabala C, Merino MJ. Role of chomogenic in Situ Hybridization (CISH ^TM) in the Evaluation of HER2 status in breast carcinoma. Int J Surg Pathol 13(4):343-51, 2005. PMID: 16273190.
Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8(2):143-53, 2005. PMID: 16098467.
Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM. High frequency of somatic frameshift BHD mutations in Birt-Hogg-Dube-associated renal tumors. J Natl Cancer Inst 97(12):931-5, 2005. PMID: 15956655.
Pavlovich CP, Grubb RL, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM. Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J Urol 173(5):1482-6, 2005. PMID: 15821464.
Alleman WG, Tabios RL, Chandramouli GV, Aprelikova ON, Torres-Cabala C, Mendoza A, Rogers C, Rodgers C, Sopko NA, Linehan WM, Vasselli JR. The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine. Clin Cancer Res 10(20):7011-21, 2004. PMID: 15501981.
Schmidt LS, Nickerson ML, Angeloni D, Glenn GM, Walther MM, Albert PS, Warren MB, Choyke PL, Torres-Cabala CA, Merino MJ, Brunet J, Bérez V, Borràs J, Sesia G, Middelton L, Phillips JL, Stolle C, Zbar B, Pautler SE, Linehan WM. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyroisine kinase domain of the Met proto-oncogene. J Urol 172(4 Pt 1):1256-1261, 2004. PMID: 15371818.
Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS. Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissues. Mod Pathol 17(8):998-1011, 2004. PMID: 15143337.
Torres-Cabala C, Panizo-Santos A, Krutzsch HC, Barazi H, Namba M, Sakaguchi M, Roberts DD, Merino MJ. Differential expression of S100C in thyroid lesions. Int J Surg Pathol 12(2):107-115, 2004. PMID: 15173915.
Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, Worrell R, Torres-Cabala C, Tabios R, Mariotti A, Stearman R, Merino M, Walther MM, Simon R, Klausner RD, Linehan WM. Predicting survival in patients with metastatic kidney cancer by gene expression profiling in the primary tumor. Proc Natl Acad Sci U S A 100(12):6958-63, 2003. e-Pub 2003. PMID: 12777628.
Arudra K, Patel R, Tetzlaff MT, Hymes S, Subbiah V, Torres-Cabala CA, Aung PP, Nagarajan P, Diab A, Prieto VG, Nelson K, Curry JL. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. Journal of Cutaneous Pathology.
Trinidad CM, Nelson KC, Glitza-IC, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Ivan D, Prieto VG, Curry JL, Aung PP. Interstitial Granulomatous Dermatitis: A novel toxicity from immune checkpoint blockade therapy-Case Report. Journal of Cutaneous Pathology.

Invited Articles

Curry JL, Falchook GS, Torres-Cabala CA, Tetzlaff MT, Prieto VG. Resistant mechanisms to BRAF inhibitor PLX4032 in melanoma. Expert Review of Dermatology 6(4):355-357, 2011.

Manuals, Teaching Aids, Other Teaching Publications

Torres-Cabala CA, Linehan WM, Merino MJ.. Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions. Surgical Pathology II Check Sample Exercise. ASCP, 2005.

Editorials

Giubellino A, Torres-Cabala CA. Editorial for Special Issue "Molecular Mechanisms and Signaling Pathways in Melanoma". Cancers (Basel) 15(19):4675, 2023. PMID: 37835369.

Abstracts

Dimopoulos YP, Cunningham C, Wang WL, Ingram D, Lazcano R, Nagarajan P, Curry JL, Torres-Cabala, CA Prieto VG, Cho WC, Aung P. Vascular Changes in Merkel Cell Carcinoma: Prevalence, Association with Local VEGF Expression, and Prognostic Implications. Modern Pathology 2023 USCAP Meeting 103(3):398-399, 2023.
Gill P, Middleton L, Zhang J, Keiser E, Ding QQ, Li Z, Duose D, Hernandez S, Arrechedera C, Aung P, Torres-Cabala CA, Curry JL, Cho WC, Prieto VG, Ivan D, Nagarajan P. Comparative Transcriptomic Analyses Distinguish Cutaneous Squamoid Eccrine Ductal Carcinomas from Low-Grade Adenosquamous Carcinomas of the Breast. Modern Pathology 2023 USCAP Meeting 103(3):403-404, 2023.
Liu Y, Torres-Cabala CA, Wang D, Shah M, Cho WC, Nagarajan P, Curry J, Ivan D, Prieto VG, Ballester B, Aung P. Metabolomic Profiling in Acral Melanomas Reveals Key Metabolic Pathway Gene Differences Compared with Non-acral Melanomas. Modern Pathology 2023 USCAP Meeting 103(3):412-413, 2023.
Liu Y, Aung P, Ding QQ, Nagarajan P, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG, Cho WC. TRPS1 May be an Effective Discriminatory Marker for Basal Cell Carcinoma and Squamous Cell Carcinoma: An Immunohistochemical Analysis of TRPS1 in Non-Melanocytic Cutaneous Neoplasms. Modern Pathology 2023 USCAP Meeting 103(3):413-414, 2023.
Nagarajan P, Zhang J, Davies M, Bassett R, Duose D, Aung P, Torres-Cabala CA, Cho WC, Curry JL, Ivan D, Prieto VG, Tetzlaff MT, Pettaway C. Pilot Clinical and Transcriptomic Analysis of Male Genitourinary Melanoma. Modern Pathology 2023 USCAP Meeting 103(3):423, 2023.
Rahbar Z, Aung P, Shen L, Yang R, Zambrano SC, Castaneda C, Castillo M, Pattanaprichakul P, Cho WC, Nagarajan P, Wang J, Prieto P, Curry J, Torres-Cabala CA. Whole Exome Sequencing of Acral Lentiginous Melanoma Reveals Novel Somatic Mutations and Potential Differences in Patients from Different Ethnicities. Modern Pathology 2023 USCAP Meeting 103(3):427-428, 2023.
Ryu HJ, Kim C, Jang H, Kim Sun II, Shin SJ, Torres-Cabala CA, Kim SK. Nuclear Localization of YAP Protein is Associated with Tumor Progression in Cutaneous Melanoma. Modern Pathology 2023 USCAP Meeting 103(3):436-437, 2023.
Aung P, Gill P, Lai Z, Zhu K, Vasudevaraja V, Ivan D, Nagarajan P, Cho WC, Ballester L, Curry JL, Torres-Cabala CA, Prieto VG, Jour G. Multi-omics Analysis of Digital Papillary Adenocarcinoma Reveals Upregulation of MAGEA4 and Infrequent Zinc Finger Genes Rearrangements. 2022 USCAP Annual Meeting, 2022.
Cho WC, Ding Q, Wang WL, Nagarajan P, Curry JL,Torres-Cabala CA, Ivan D, Albarracin CT, Sahin A, Prieto VG, Aung P. TRPS1 Expression is Frequently Seen in Mammary and Extramammary Paget Diseases, Except for Those Arising in the Perianal Skin. 2022 USCAP Annual Meeting, 2022.
Gill P, Milton DR, Ballester LY, Cho WC, Nagarajan P, Curry JL, Ivan D, Prieto VG, Davies M, Torres-Cabala CA, Aung P. Characterizing the Clinicopathologic and Molecular Landscape of Acral Lentiginous Melanoma: A Retrospective Review of 331 Patients. 2022 USCAP Annual Meeting, 2022.
Gill P, Teny J, Tarrand J, Jiang X, Ning J, Aung P, Cho WC, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Nagarajan P. Cutaneous Deep Fungal Infections: Retrospective at a Tertiary Care Cancer Center. 2022 USCAP Annual Meeting, 2022.
Lazcano R, Hernandez S, Mehta J, Cho WC, Parra E, Solis Soto L, Zambrano SC, Castillo M, Castaneda C, Nagarajan P, Curry JL, Wistuba I, Prieto VG, Aung P, Torres-Cabala CA. PD-L1 Expression by Tumor-Associated Macrophages (TAMS) of M2 Subtype is Associated with Overall Survival in Acral Lentiginous Melanoma of Different Ethnicities. 2022 USCAP Annual Meeting, 2022.
Ronen S, Billings S, Mcniff J, Torres-Cabala CA, George S, Heberton M, Valencia T, Aung P, Curry JL, Cho WC, Ivan D, Prieto VG, Nagarajan P. Extramammary Post-Radiation Atypical Vasacular Lesions: A Clinicopathologic Study of Eight Cases. 2022 USCAP Annual Meeting, 2022.
Rothrock A, Cho WC, Nagarajan P, Curry JL, Vanderbeck K, Ivan D, Prieto VG, Torres-Cabala CA, Aung P. Diagnostic Utility of PRAME Immunohistochemistry in Subungual and Acral Melanocytic Lesions. 2022 USCAP Annual Meeting, 2022.
Saade R, Cho WC, Nagarajan P, Aung P, Marques-Piubelli M, Hudgens C, Ledesma D, Nelson K, Heberton M, Ivan D, Zhang M, Torres-Cabala CA, Campbell M, Prieto VG, Wistuba I, Esmaeli B, Curry JL. High Expression of Nectin-4 in a Subset of Adnexal Carcinomas: A potential Target for Enfortumab Vedotin Therapy. 2022 USCAP Annual Meeting, 2022.
Vanderbeck K, Milton DR, Nagarajan P, Rothrock A, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung P, Cho WC. SOX11 Serves as an Effective Discriminatory Marker, When Used in Conjunction with CK20 and TTF1 Expressions in Merkel Cell Carcinomas and Pulmonary Small Cell Carcinomas. 2022 USCAP Annual Meeting, 2022.
Marques-Piubelli ML, Ledesma DA, Hudgens CW, Bota Rabadessas MN, Huen A, Duvic M, Miranda RN, Curry JL, Torres-Cabala CA. Differences in Th Phenotypes Between Granulomatous and Classic Mycosis Fungoides. International Society Cutaneous Lymphomas (ISCL)-Virtual, 2021.
Torres-Cabala CA, Cho WC. Quantitative Multiplex Immunofluorescence Analysis Identifies Racial Differences in the Immune Landscape of Acral Lentiginous Melanomas in Caucasian and Hispanic Patients. Division of Pathology & Laboratory Medicine 1st Annual Research Symposium, 2021.
Yang RK, Ronen S, Bell AH, Nagarajan P, Curry JL, Ivan D, Prieto VG, Torres-Cabala CA, Aung PP. MicroRNA Expression Signature Differentiates Primary Lentiginous from Non-Lentiginous Acral Melanoma. Presentation. 2021 USCAP Virtual Meeting, 2021.
Gill P, Namikawa K, Milton D, Cho WC, Nagarajan P, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA, Aung PP. Characterizing the Moelcular Landscape of Acral Lentiginous Melanoma: A Multi-National Study of 429 Patients. Presentation. 2021 USCAP Virtual Meeting, 2021.
Cho WC, Li W, Gu J, Wang WL, Ning J, Sfamenos SM, Gill P, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Prieto VG, Torres-Cabala CA, Aung PP. The Utility of Telomerase Reverse Transcriptase Immunohistochemistry as a Surrogate Marker of TERT Gene Amplification Status in Acral Lentiginous Melanoma. Presentation. 2021 USCAP Virtual Meeting, 2021.
Cho WC, Segura RNL, Soto LMS, Parra ER, Zambrano SAC, Castillo M, Castaneda C, Gill P, Nagarajan P, Ivan D, Curry JL, Wistuba II, Prieto VG, Torres-Cabala CA, Aung PP. Characterization of the Immune Landscape of Acral Lentiginous Melanomas in Caucasian and Hispanic Populations. Presentation. 2021 USCAP Virtual Meeting, 2021.
Lai Z, Jour G, Ivan D, Torres-Cabala CA, Nagarajan P, Zhang B, Duose D, Curry JL, Prieto VG, Aung PP. Exploratory Transcriptomic Analyses of Tumor and Mirco-enviroment Signatures in Aggressive Digital Papillary Adenocarcinoma. Presentation. 2021 USCAP Virtual Meeting, 2021.
Gill P, Zhang J, Lee J, Duose D, Cho WC, Keiser E, Aung PP, Tetzlaff MT, Torres-Cabala CA, Curry JL, Prieto VG, Ivan D, Nagarajan P. Squamoid Eccrine Ductal Carcinoma: A Clinicopathologic and Transcriptomic Profiling. Presentation. 2021 USCAP Virtual Meeting, 2021.
Fang H, El Hussein S, Shimin H, Torres-Cabala CA, Medeiros J, Khoury J. Expression Pattern and Diagnostic Utility of BCL11B in T and NK-cell Neoplasms. Presentatiion. 2021 USCAP Virtual Meeting, 2021.
Ronen S, Nagarajan P, Curry JL, Aung PP, Ivan D, Prieto VG, Torres-Cabala CA, Tetzlaff MT. Phenotypic Switch in Mycosis Fungoides: A Tertiary Cancer Center Experience. Presentation. 2021 USCAP Virtual Meeting, 2021.
Woo WC, Gill P, Gu J, Aung PP, Nagarajan P, Curry JL, Ivan D, Prieto VG, Torres-Cabala CA. The Utility of Digital Pathology in Improving Diagnostic SKills of Pathology Trainees in Commonly Encountered Pigmented Cutaneous Lesions during the COVID-19 Pandemic: A Single Academic Institution Experience. Presentation. 2021 USCAP Virtual Meeting, 2021.
Ali Y, Meis JMM, Thomas V, Wang W, Torres-Cabala CA, Hymes S, Alousi A, Moon B, Roland C, Wong M, Conley A, Tetzlaff MT, Curry JL, Ivan D, Aung P, Prieto VG, Nagarajan P. Chronic Sclerodermoid Dermatosis-associated Aggressive Cutaneous Squamous Cell Carcinomas: Report of 3 Cases. 57th Annual ASDP Meeting-Virtual, 2020.
Collins K*, Aung PP, Gu J, Nagarajan P, Curry JL, Ivan D, Prieto VG, Tetzlaff MT, Huen A, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is GATA-3 helpful in the differential diagnosis between transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? A study of 48 cases. Oral Presentation (*Best Resident Presentation). 57th Annual ASDP Meeting-Virtual, 2020.
Gill P, Richards K, Cho WC, Nagarajan P, Aung PP, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Localized cutaneous argyria associated with a sliver ring clinically mimicking a melanocytic lesion. Oral Presentation. 57th Annual ASDP Meeting-Virtual, 2020.
Cho WC, Gill P, Huen A, Heberton M. Aung P, Torres-Cabala CA, Curry JL, Ivan D, Prieto VG, Khoury J, Nagarajan P. Megakaryocytes in Skin: an Important Clue to Underlying Hematologic Disorders. 57th Annual ASDP Meeting-Virtual, 2020.
Cho WC, Gill P, Nagarajan P, Aung P, Torres-Cabala CA, Curry JL, Ivan D, Lester L, Prieto VG. Monotypic Cutaneous Lymphoid Hyperplasia Secondary to Tick Bite: A Hidden Critter and the Power of Deeper Levels. 57th Annual ASDP Meeting- Virtual, 2020.
Cho WC, Wang W, Milton D, Ingram D, Nagarajan P, Curry JL, Ivan D, Lazar A, Prieto VG, Torres-Cabala CA, Aung P. Prognostic and Diagnostic Role of Tert Protein Expression in Acral Lentiginous Melanoma Compared to Other Types of Cutaneous Melanoma and Acral Nevus. 57th Annual ASDP Meeting-Virtual, 2020.
Nagarajan P, Westerman M, Bassett R, Tamboli P, Li R, Jones A, Haydu L, Prieto VG, Curry JL, Torres-Cabala CA, Ivan D, Aung P, Gershenwald J, Davies M, Tetzlaff MT, Pettaway C. Prognostic Model for T-Categorization of Primary Male Genitourinary Melanoma (MGUM). 57th Annual ASDP Meeting-Virtual, 2020.
Gill P, Cho W, Tarrand K, Francisco D, Mulanovich V, Fayad L, Heberton M, Huen A, Aung P, Torres-Cabala CA, Curry JL, Ivan D, Prieto VG, Tetzlaff MT, Nagarajan P. Pseudo-Dimorphism in Cutaneous Deep Fungal Infections. 57th Annual ASDP Meeting-Virtual, 2020.
Gill P, Richards K, Cho WC, Nagarajan P, Aung PP, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Localized cutaneous argyria associated with a silver ring clinically mimicking a melanocytic lesion. Oral Presentation. 57th Annual ASDP Meeting-Virtual, 2020.
Collins K,* Aung PP, Gu J, Nagarajan P, Curry J, Ivan D, Prieto VG, Tetzlaff MT, Huen A, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is GATA-3 helpful in the differential diagnosis between transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? A study of 48 cases. Oral Presentation (*Best Resident Presentation). 57th Annual ASDP Meeting-Virtual, 2020.
Aung P, Namikawa K, Milton D, Nagarajan P, Tetzlaff MT, Curry J, Ivan D, Torres-Cabala CA, Prieto VG. Correlation between Metastatic Tumor Burden in Sentinel and Non-Sentinel Lymph Nodes and Prognostic Significance of Tumor Burden in Sentinel Nodes in 336 Patients with Cutaneous Melanoma: A Single-Institution Retrospective Study. 2020 USCAP Meeting, 2020.
Cho WC, Prieto VG, Gruschkus S, Bassett R, Torres-Cabala CA, Tetzlaff MT, Curry JL, Aung p, Ivan D, Nagarajan P. Primary Cutaneous Melanoma of the Umbilicus: A Retrospective Study of 18 Patients. 2020 USCAP Meeting, 2020.
Keiser E, Ronen S, Al-Rohil R, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG, Aung P. Factors Associated with Patient Outcomes After Diagnosis with Invasive Melanoma: An 8-Year Retrospective Study of AJCC Staging and Clinical Parameters. 2020 USCAP Meeting, 2020.
Keiser E, Ronen S, Ivan D, Torres-Cabala CA, Tetzlaff MT, Curry JL, Aung P, Prieto VG, Nagarajan P. Squamoid Eccrine Ductal Carcinoma: Elucidating Clinicopathologic Features of Prognostic Significance. 2020 USCAP Meeting, 2020.
Marques-Piubelli M, Tetzlaff MT, Muhlbauer A, Wang J, Nelson K, Nagarajan P, Aung P, Torres-Cabala CA, Pacha O, Prieto V, Subramanya S, Wistuba I, Curry JL. Differentially Expressed Genes in Bullous Pemphigoid Immune-Related Adverse Event (BP-irAE) from Immune Checkpoint Inhibitor Therapy: Implications in the Immunopathogenic Mechanisms Driving BP-irAE Compared to De Novo BP Control. 2020 USCAP Meeting, 2020.
Mejbel H, Mori T, Torres-Cabala CA, Milton D, Muto Y, Nakama K, Yamazaki N, Nagarajan P, Tetzlaff MT, Ivan D, Curry JL, Hwu W, Prieto VG, Namikawa K, Aung P. Comparative Study of Acral Lentiginous Melanoma in Patients from USA and Japan. 2020 USCAP Meeting, 2020.
Pradhan D, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman E, Hwu W, Prieto VG, Torres-Cabala CA, Aung P. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. 2020 USCAP Meeting, 2020.
Ramani N, Gu J, Aung P, Sfamenos S, Sdringola-Maranga C, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Diab A, Hwu W, Prieto VG, Torres-Cabala CA. TERT Amplification is Involved in Acral Lentiginous Melanoma Progression to Metastasis. 2020 USCAP Meeting, 2020.
Zaleski M, Jour G, Milton D, Diab A, Hwu W, Prieto VG, Torres-Cabala CA, Aung P. Gene Expression of the Tumor Micro Environment in Acral Lentiginous Melanoma. 2020 USCAP Meeting, 2020.
Ronen S, Keiser E, Collins K, Aung P, Nagarajan P, Tetzlaff MT, Ivan D, Curry J, Prieto VG, Torres-Cabala CA. Multiple Skin Lesions Showing Pleomorphic Epithlioid Cells in a Patient with a History of Metastatic Melanoma and Langerhans Cell Histiocytosis. 56th Annual ASDP Meeting, 2019.
Keiser E, Ronen S, Tetzlaff MT, Torres-Cabala CA, Durel R, Lucci A, Holbrook K, Tawbi H, Nagarajan P. Multifocal Blue Nevus Type Melanoma Arising in Association with Blue Nevus. 56th Annual ASDP Meeting, 2019.
Ronen S, Keiser E, Torres-Cabala CA, Durel R, Lucci A, Holbrook K, Tawbi H, Nagarajan P. Liver Mass with Expression of Melanocytic Markers in a Patient with a History of Metastatic Melanoma: is it Metastatic Melanoma?. 56th Annual ASDP Meeting, 2019.
Keiser E, Ronen S, Nagarajan P, Aung P, Tetzlaff MT, Ivan D, Curry J, Prieto VG, Torres-Cabala CA. Intraoperative Consult for Basal Cell Carcinoma of the Scalp with Prominent Telangiectasia: When Looking Deeper Isn't Just About Levels. 56th Annual ASDP Meeting, 2019.
Ronen S, Kwon D, Keiser E, Aung P, Nagarajan P, Tetzlaff MT, Ivan D, Curry J, Prieto VG, Torres-Cabala CA. Epithelial Mesenchymal Transition in Cutaneous Adnexal Carcinoma. 56th Annual ASDP Meeting, 2019.
Piubelli M, Tetzlaff MT, Nagarajan P, Nelson K, Duke T, Glitza Oliva I, Ledesma D, Torres-Cabala CA, Wistuba I, Prieto VG, Curry JL. Hypertrophic Lichenoid Dermatitis Immune-related Adverse Event From Immune Checkpoint Inhibitor Therapy: A Pitfall for Superficially Invasive Squamous Cell Carcinoma. 56th Annual ASDP Meeting, 2019.
Roy M, Sahin A, Teshome M, Damodaran S, Arribas E, Candelaria R, Albarracin C, Tetzlaff MT, Curry JL, Torres-Cabala CA, Aung P, Ivan D, Prieto VG, Nagarajan P. Clinically Silent Male Mammary Paget Disease. 56th Annual ASDP Meeting, 2019.
Pye A, Robinson C, Kash N, Torres-Cabala CA, Hymes S. Blastic plasmacytoid dendritic cell neoplasm manifesting as ichthyosis. Gross & Microscopic Symposium, American Academy of Dermatology Meeting, 2019.
Ramani N, Aung PP, Gu J, Sfamenos S, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Hwu WJ, Prieto VG, Torres-Cabala CA. LEF-1 and b-catenin expression in acral lentiginous melanoma. Oral Presentation. ISDP Annual Meeting, 2019.
Pye A, Robinson C, Kash N, Torres-Cabala CA, Hymes S. Blastic plasmacytoid dendritic cell neoplasm manifesting as ichthyosis. The Texas Dermatological Society Fall Meeting, 2018.
Amaria RN, Trinh VA, Gu J, McIntyre S, Torres-Cabala CA, Simien R, Diab A, Tawbi HA, Davies MA, Wong MK, Hwu P, Glitza IC, Patel SP, Hwu WJ. Treatment strategies using anti-PD1/PD-L1 (anti-PD) and BRAF/MEK inhibitor (BRAFi) therapy: a restrospective study comparing sequential vs. concurrent administration in BRAF-mutated metastatic melanoma (BMMM). AACR Annual Meeting, 2018.
Jour G, Prieto VG, Torres-Cabala CA, Andeen NK, Yang J, Sulman EP, Aung PP. Compartive Methylome Analysis in Cutaneous Malignant Peripheral Nerve Sheath Tumors and/Spindle Desmoplastic Melanomas. Poster Presentation. 2018 USCAP Meeting, 2018.
Arudra SKC, Ivan D, Chen WS, Nagarajan P, Aung PP, Curry JL, Ortega VA, Torres-Cabala CA, Tetzlaff MT, Prieto VG. Destaining-Restaining Immunostudies Combined with Whole-Slide Scanning: A Helpful Tool in Dermatopathology, Poster Presentation. 2018 USCAP Meeting, 2018.
Trinidad CM, Tetzlaff MT, Ivan D, Nagarajan P, Torres-Cabala CA, Curry JL, Esmaeli B, Prieto VG, Aung PP. Expression of Neuroendocrine Markers in Sebaceous Carcinoma: A potential Diagnostic Pitfall. Poster Presentation. 2018 USCAP Meeting, 2018.
Aung PP, Barua S, Parra ER, Mino B, Curry JL, Nagarajan P, Torres-Cabala CA, Lazar A, Wistuba I, Prieto VG, Tetzlaff MT. Multiplex Immunofluorescence (mIF) and novel computational method demonstrates co-expression of B7-H3 in tumor-associated CD31+ endothelium of Merkel cell carcinoma (MCC). Poster Presentation. 2018 USCAP Meeting, 2018.
Trinidad CM, Tetzlaff MT, Ivan D, Nagarajan P, Torres-Cabala CA, Curry JL, Prieto VG, Aung PP. Recurrent/Persistent Nevus: A Clinical and Histologic Evaluation of Features Associated with Recurrence and Persistence of Melanocytic Nevi. Poster Presentation. 2018 USCAP Meeting, 2018.
Yildiz P, Hruska C, Ivan D, Aung PP, Curry JL, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Prieto VG. The Prognostic Impact of Tumor Thickness by Using Different Measurement methods in Cutaneous Squamous Cell Carcinomas. Poster Presentation. 2018 USCAP Meeting, 2018.
Pradhan D, Ivan D, Nelson K, Torres-Cabala CA, Tetzlaff MT, Curry JL, Nagarajan P, Prieto VG, Aung P. "Melanocarcinoma", a Rare But Diagnostic Pitfall. ASDP 55th Annual Meeting, 2018.
Pradhan D, Khoury J, Aung P, Tetzlaff MT, Torres-Cabala CA, Curry JL, Ivan D, Prieto VG, Nagarajan P. Colincident Merkel Cell Carcinoma And Mantle Cell Lymphoma. 55th Annual ASDP Meeting, 2018.
Aung P, Ivan D, Milton D, Nagarajan P, Tetzlaff MT, Curry JL, Prieto VG, Hwu WJ, Torres-Cabala CA. Is Subungual Location a Prognostic Factor for Acral Lentiginous Melanoma?. 55th Annual ASDP Meeting, 2018.
Pradhan D, Arudra SK, Prieto VG, Ballester L, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Luthra R, Aung P. Next-Generation Sequencing-Based Molecular Characterization of Histophenotypic Plasticity in Primary and Metastatic Melanoma. 55th Annual ASDP Meeting, 2018.
Saenz-Ibarra B, Nagarajan P, Torres-Cabala CA, Prieto VG, Huen A, Aung P. Significance of Deeper H&E Tissue Sections in Dermatopathology. 55th Annual ASDP Meeting, 2018.
Nagarajan P, Pettaway C, Davies M, Bassett Jr. R, Haydu L, Li R, Jones A, Tamboli P, Curry JL, Torres-Cabala CA, Ivan D, Aung P, Gershenwald J, Prieto VG, Tetzlaff MT. Tumor Thickness Correlates with Regional Metastasis in Male Genitourinary Melanoma. 55th Annual ASDP Meeting, 2018.
Saenz B, Prieto VG, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Disseminated Coccidioidomycosis: A Mimicker of Metastatic Disease. ASDP 54th Annual Meeting, 2017.
Chen Wei-Shen, Chen Pei-Ling, Prieto VG, Tetzlaff MT, Torres-Cabala CA, Curry JL, Aung PP, Ivan D, Nagarajan P. Disseminated Nocardiosis Presenting as Multiple Cutaneous Lesions. ASDP 54th Annual Meeting, 2017.
Arudra SKC, Prieto VG, Ballester L, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Chen Wei-Shen, Kudo Y, Duose D, Luthra R, Aung PP. Correlation Between Phenotype and Genotype in Melanoma with Different Morphologies: A study of 3 Cases Using Next Generation Sequencing (NGS). ASDP 54th Annual Meeting, 2017.
Arudra SKC, Tetzlaff MT, Aung PP, Torres-Cabala CA, Curry JL, Ivan D, Prieto VG, Nagarajan P,. Extracephalic Primary Cutaneous Osteoinvasive Squamous Cell Carcinoma: A Case Series. ASDP 54th Annual Meeting, 2017.
Arudra SKC, Aung PP, Nagarajan P, Curry JL, Tetzlaff MT, Torres-Cabala CA, Prieto VG, Ivan D,. Zuska's Disease Mimicking Squamous Cell Carcinoma: A Diagnostic Challenge. ASDP 54th Annual Meeting, 2017.
Dolkar T, Nelson K, Rodabe A, Torres-Cabala CA, Curry JL, Ivan D, Nagarajan P, Tetzlaff MT, Prieto VG, Aung PP. Lichenoid Dermatologic Toxicity from Novel Therapy Using Antimicrobial Peptide LL-37 in Melanoma: A Detailed Examination of the Clinicopathologic Features. ASDP 54th Annual Meeting, 2017.
Arudra SKC, Aung PP, Tetzlaff MT, Curry JL, Nagarajan P, Ivan D, Prieto VG, Hwu W, Wang WL, Torres-Cabala CA. A Dual PD-L1/SOX-10 Immunohistochemical Study Combined with Digital Imaging Enhances Accuracy in Stratifying Metastatic Melanoma Patients for Immune Checkpoint Therapy. Oral Presentation. ASDP 54th Annual Meeting, 2017.
Nagarajan P, Samdani R, Ning J, Piao J, Curry JL, Aung PP, Torres-Cabala CA, Ivan D, Wang WL, Ross M, Royal R, Wargo J, Rashid A, Lazar A, Noordenbos L, Gershenwald J, Davies M, Prieto VG, Tetzlaff MT. Primary Anorectal Melanoma: A Retrospective Analysis of 160 Patients. ASDP 54th Annual Meeting, 2017.
Al-Rohil R, Jour G, Nagarajan P, Aung PP, Tetzlaff MT, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG. Discordances in Evaluation of Melanocytic Lesions and Its Impact on Management: A Study of 1518 Cases. 2017 USCAP Meeting, 2017.
Mauzo S, Prieto VG, Siroy AE, Ivan D, Tetzlaff MT, Nagarajan P, Milton D, Curry JL, Torres-Cabala CA, Aung PP. Expression of PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. 2017 USCAP Meeting, 2017.
Samdani R, Tetzlaff MT, Curry JL, Ning J, Piao J, Aung PP, Torres-Cabala CA, Ivan D, Wang WL, Lazar AJ, Ross MI, Royal RE, Wargo JA, Gershenwald JE, Davies MA, Prieto VG, Rashid A, Nagarajan P. Primary Anorectal Melanoma: A Retrospective Analysis of 30 Patients. 2017 USCAP Meeting, 2017.
Siroy AE, Sui D, Ning J, Luthra R, Patel KP, Routbort MJ, Broaddus RR, Nagarajan P, Aung PP, Ivan D, Curry JL, Torres-Cabala CA, Prieto VG, Davies MA, Lazar AJ, Tetzlaff MT. An Assessment of Copy Number Variations and Somatic Mutations in Advanced Melanomas by Clinical Next-Gerneration Sequencing. 2017 USCAP Meeting, 2017.
Aung PP, Nejati R, Loghavi S, Zuo Z, Chen W, Torres-Cabala CA, Konopleva M, Tang Z, Mederios LJ, Prieto VG, Naveen P, Khoury J. PD-L1 Protein and mRNA Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. 2017 USCAP Meeting, 2017.
Castaneda C, Torres-Cabala C, Castillo M, VIllegas S, Casavilca S, Cano L, Sanchez J, Dunstan J, Calderon G, De La Cruz M, Cotrina JM, Gomez HL, Galvez R, Abugarras J.. Acral lentiginous melanoma and infiltrating lymphocytes in a Latin American population. AACR Annual Meeting, 2017.
Al-Rohil RN, Feldmeyer L, Nagarajan P, Lyons GR, Curry JL,Torres-Cabala, CA, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Intratumoral Lymphovascular Invasion Detected by D2-40 Correlates with Metastasis in Primary Cutaneous Merkell Cell Carcinoma. Laboratory Investigation 96(Supplement 1):125A-126A, 2016.
Aung PP, Ravishankar S, Friedman K, Milton DR, Curry JL,Torres-Cabala CA, Ivan D, Tetzlaff MT, Gershenwald JE, Prieto VG, Nagarajan P,. Prognostic Significance of Regression in Patients with Thin Primary Cutaneous Melanoma. Laboratory Investigation 96(Supplement 1):126A, 2016.
Nagarajan P, Curry JL, Ning J, Piao J, Aung PP, Ivan D,Torres-Cabala, CA, Prieto VG, Malpica A, Tetzlaff MT. Melanomas of the Vulva: A Retrospective Analysis of Clinical and Histopathologic Parameters in 40 Patients. Laboratory Investigation 96(Supplement 1):134A, 2016.
Siroy AE, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Prieto VG, Aung PP. Clinical Significance of BRAF V600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma. Laboratory Investigation 96(Supplement 1):136A, 2016.
Tetzlaff, MT, Feldmeyer L, Lyons GR, Curry JL, Aung PP, Nagarajan P, Ivan D, Torres-Cabala CA, Bassett RL, Wargo JA, Prieto VG. The Composition, Density, and Location of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma. Laboratory Investigation 96(Supplement 1):137A, 2016.
Wimmer D, Tetzlaff MT, Torres-Cabala CA, Milton DR, Nagarajan P, Aung PP, Prieto VG, Curry JL,. Immunodetection of Mitotic Figures and G2+ Tumor Nuclei with Histone Markers in Stage III Melandoma Samples. Laboratory Investigation 96(Supplement 1):139A, 2016.
Jour G, Aung PP, Nagarajan P, Tetzlaff MT, Merrill E, Curry J, Prieto V, Miranda R, Torres-Cabala, CA. Primary Cutaneous Gamma-Delta T Cell Lymphomas Do Not Display TH2 Chemokine Expression: Significance For Diagnosis and Therapy. 19th Joint Meeting, International Society of Dermatopathology, 2016.
Aung PP, Nagarajan P, Ivan D, Tetzlaff MT, Curry JL, Prieto VG, Torres-Cabala CA. Partial Loss of CD123+ expression after treatment with SL-401 in patients with Blastic Plasmacytoid Dendritic Cell Neoplasm. 19th Joint Meeting, International Society of Dermatopathology, 2016.
Merrill ED, Miranda RN, Aung PP, Tetzlaff MT, Agbay RL, Curry JL, Prieto VG, Duvic M, Medeiros LJ, Torres-Cabala CA. Primary cutaneous ysT-cell lymphoma with a predominantly epidermotropic pattern. 74th Annual Meeting, American Academy of Dermatology, 2016.
Feldmeyer L, Fox P, Tetzlaff MT, Curry JL, Nagarajan P, Ivan D, Torres-Cabala CA, Prieto V, Aung P.. Prognostic Significance of Lymphovascular Invasion Detected By Immunostaining With D2-40 and D2-40/MITF1 in Patients With Cutaneous Melanoma. Laboratory Investigation 95(Supplement 1):120A, 2015.
Mudaliar K, Torres-Cabala CA, Tetzlaff MT, Duvic M, Ciurea A, Hymes S, Tsai K, Prieto V, Curry JL.. Vemurafenib Associated Melanocytic Lesions Lack BRAFV600E Mutation and Show Preserved BAP1 Expression. Laboratory Investigation 95(Supplement 1):125A, 2015.
Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox P, Patel K, Estrella J, Broaddus R, Davies M, Routbort M, Lazar A, Prieto V, Hwu WJ, Gershenwald J, Woodman S, Torres-Cabala CA, Curry JL.. Utility of BRAFV600E Immunohistochemistry (IHC) Expression Pattern as a Surrogate of BRAFV600 Mutation Status in 154 Patients With Advanced Stage Melanoma. Laboratory Investigation 95(Supplement 1):126A, 2015.
Al-Rohil R, Curry JL, Torres-Cabala CA, Ivan D, Bassett R, Prieto V, Tetzlaff MT.. The Contribution of Second Generation Fluorescence In Situ Hybridization (FISH) To histopathologic and Immunophenotypic Analyses in the Diagnosis of Ambiguous Melanocytic Tumors (AMT). Laboratory Investigation 95(Supplement 1):495A, 2015.
Danialan R, Kudakwashe M, Curry JL, Torres-Cabala CA, Ivan D, Nagarajan P, Aung P, Prieto V, Tetzlaff MT.. The Impact of Second-Opinion Dermatopathology Review on Melanoma Management and Stage at a Tertiary Cancer Referral Center. Laboratory Investigation 95(Supplement 1):498A, 2015.
Alberti-Violetti S, Talpur R, Torres-Cabala CA, Corti L, Berti E, Duvic M.. Primary Cutaneous Small to Medium-Size CD4+ Pleomorphic T-Cell Lymphoma: 48 Patients from Two Independent Centers and Revaluation of Clinico-Histological Criteria for Differential Diagnosis from Other CTCL. Blood Journal, 2014.
Chen J, Creasy C, Torres-Cabala CA, Ekmekcioglu S, Maiti SN, Kale C, Haymaker C, Roszik J, Bassett R, Hu J.. Predictive immune biomarker signatures in the tumor microenviroment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy. Journal for Immuno Therapy of Cancer, 2014.
Oh, CW, Ivan D, Duvic M, Gerber H, Torres-Cabala C. "A Case of Indeterminate Cell Tumor Presenting with Leonine Facies". The America Society of Dermatopathology (ASDP), 2014.
Li J,Kash N, Garner A, Torres-Cabala CA, Duvic M. "Retiform Hemangioendothelioma: An Atypical Case Mimicking Scleromyxedema". Texas Dermatological Society Meeting, 2014.
Scalise GD, Curry JL, Patel K, Tetzlaff MT, Prieto VG, Bueso-Ramos C,Torres-Cabala CA. Leucemia cutis simulando Sindrome de Sweet histiocitoide. Winter Annual Meeting Invernal. Argentinian Society of Pathology, 2014.
Sweeney, SA, Yang, B, Torres Cabala CA, Hymes, SR.. A Subcutaneous Nodule in an Immunosuppresses Patient. Texas Dermatology Society Meeting, 2014.
MM De la Garza Bravo, KP Patel, JL Curry,CA Torres-Cabala,DS Ivan,J Medeiros,VG Prieto,M Duvic,MT Tetzlaff. Shared Clonality in Distinctive Lesions of Lymphomatoid Papulosis and Mycosis Fungoides Occurring in the Same Patients Suggess a Common Origin. Laboratory Investigation 94, 2014.
SA Henderson, JL Curry, CA Torres Cabala, DS Ivan, RL Bassett, VG Prieto, MT Tetzlaff. p40 Improves Diagnostic Specificity between Atypical Fibroxanthoma and Poorly Differentiated Squamous Cell Carcinoma. Laboratory Investigation 94, 2014.
SA Henderson, MT Tetzlaff, P Pattanaprichakul, PS Fox,CA Torres-Cabala, RL Bassett, VG Prieto, HW Richards, JL Curry. Immunohistochemistry for Histone H3K79me3T80ph is Superior to PHH3 in the Detection of Mitotic and Chromatin and G2 Positive Neuclei in Merkel Carcinoma. Laboratory Investigation 94, 2014.
S Loghavi, C Torres-Cabala, J Curry, D Ivan, R Bassett, V Prieto, M Tetzlaff. Tumor Size Correlates with Survival in Melanomas Associated with Conventional or Cellular Blue Nevi or Displaying Blue Nevus-Like Features (So Called Malignant Blue Nevus). Laboratory Investigation 94, 2014.
P Pattanaprichakul, S Casavilca, M Tetzlaff, L Cano, P Sitthinamsuwan, C Barrionuevo, S Kumnerdnakta, N Ramani, V Prieto, J Curry,C Torres-Cabala. Primary Acral Lentiginous Melanom in Patients with Non-Caucasian Ethnicities from East Asia and Latin America Demonstrates Frequent Heterogenous Immunodetection of BRAFV600E and Preserved PTEN Protein Expression. Laboratory Investigation 94, 2014.
Chen JQ, Creasy C, Torres-Cabala CA, Ekmekcioglu S, Maiti SN, Roszik J, Haymaker C, Bernatchez C, Hwu P, Radvanyi L. Predictive immune biomarker signatures in the tumor microenviroment of melanoma metastases associated with response to tumor-infiltrating lumphocyte (TIL) therapy. AACR Special Conference on Cellular Heterogeneity in the Tumor Microenviroment, 2014.
Chen JQ, Creasy C Torres-Cabala C, Radvanyi L.. Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy. SITC, 2013.
Lee N, Curry J, Duvic M, Miranda R, Tetzlaff M, Prieto V, Bueso-Ramos C, Torres-Cabala C.. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPCN) shows frequent association with acute myeloid leukemia (AML): a single institution experience. ASDP, 2013.
Pattanaprichakul P, Tetzlaff M, Torres-Cabala C. Henderson S, Papadopoulos N, Prieto V, Curry J.. Malignant neurocristic hamartoma with EWSR1 gene rearrangement detected by fluorescent in situ hybridization (FISH). ASDP, 2013.
Lee N, Duvic M, Curry J, Torres-Cabala C. Plasmacytoid Dendritic Cell Neoplasm in a Patient with a 10-Year History of Pruritus. Am J Dermatopathol 35(5):e96, 2013.
Haymaker C, Chen JQ, Bernatchez C, Kale C, Torres-Cabala C, Radvanyi L. Usurpation of a lymphocyte costimulatory molecule as a novel melanoma cell survival pathway (P2187). The Journal of Immunology 190(1), 2013.
Agarwal A, Torres-Cabala CA , Tetzlaff MT, Stockman DL, Chu V, Prieto VG, Curry JL. The Impact on Final Breslow Thickness and Sentinel Lymph Node Status with Initial Biopsies of Cutaneous Melanomas Transected at the Base. Laboratory Investigation 93(Suppl 1):110A, 2013.
Kapil JP, Chakravarti N, Curry JL, Wang W-L, Prieto VG, Tetzlaff MT, Torres-Cabala CA. Evaluation of Fumarate Hydratase and Hypoxia-Associated Proteins in HLRCC Syndrome and Sporadic Cutaneous Leiomyomas. Laboratory Investigation 93(Suppl 1):115A-116A, 2013.
Tetzlaff MT, Curry JL, Stockman DL, Ivan D, Wang W-L, Valencia KM, Bassett R, Torres-Cabala CA, Prieto VG. Immunodetection of Phosphohistone H3 (PHH3) as a Surrogate of Mitotic Figure Count and Clinical Outcome in Cutaneous Melanoma. Laboratory Investigation 93(Suppl 1):123A, 2013.
Dreiling JL, Linehan WM, Torres-Cabala CA, Merino MJ. The Morphologic and Molecular Heterogeneity of Papillary Renal Cell Carcinoma Type 1 May Impact Future Treatment Strategies. Laboratory Investigation 93(Suppl 1):207A, 2013.
Milless, TL, Curry JL, Torres-Cabala CA, Wang W-L, McLemore MS, Ivan D, Prieto VG, Tetzlaff MT. Diagnosing Ambiguous Melanocytic Tumors in a Tertiary Referral Center: The Contribution of Fluorescence In Situ Hybridization (FISH) to Conventional Histopathologic and Immunophenotypic Analyses. Laboratory Investigation 93(Suppl 1):478A, 2013.
Chavan R, Bridges A, Knudson R, Ketterling R, Comfere N, Wade D,Torres-Cabala C, DiCaudo D, Pittelkow M, Feldman A.. Rare chromosomal translocations of TP63 in cutaneous T-Cell lymphomas. ASDP:23, 2013.
Curry J, Chu V,Torres-Cabala C, Tetzlaff M, Prieto V.. Final tumor stage and sentinel lymph node status on initial biopsies of thin cutaneous melanomas transected at the base. J Cutan Pathol 40:131, 2013.
Kapil J, Rapini R, Curry J, Prieto V. Torres-Cabala C.. BRAF-inhibitor therapy-associated paniculitis with necrotizing granulomata: report of a case. J Cutan Pathol 40:111-112, 2013.
Milless T, Wang WL, Prieto V, McLemore M, Curry J, Ivan D, Tetzlaff M,Torres-Cabala C.. The impact of T-cell receptor gene rearrangement by PCR in mycosis fungoides. J Cutan Pathol 40:131, 2013.
Chu VH, Tetzlaff MT, Prieto VG, Torres-Cabala C, Bassett R, McLemore MS, Ivan D, Wang W-L, Curry JL. Implications of the 2009 AJCC Melanoma Staging and Classification System for Thin Melanomas. Mod Pathol 25(Suppl 2):117A-118A, 2012.
Rose CL, Curry JL, Torres-Cabala CA, Chakravarti N, Prieto VG, Tetzlaff MT. The Utility of ATF3 in Cutaneous Epithelial Neoplasms. Mod Pathol 25(Suppl 2):132A-132A, 2012.
McQuitty E, Curry J, Tetzlaff M, Prieto V, Duvic M, Torres-Cabala C. CD8-positive CD30-positive lymphomatoid papulosis and its differential diagnosis: a review of 20 cases. J Cutan Pathol 39:99, 2012.
Aung P, Curry J, Patel K, Prieto V, Duvic M, Torres-Cabala C. Immunophenotypic shift in mycosis fungoides: a case report and review of the literature. J Cutan Pathol 39:182-183, 2012.
Torres-Cabala CA, Li-Ning-Tapia EML, Ramos C, Curry JL, Prieto VG, Miranda R, Bravo F.. Expression of FOXP3 in HTLV-1-associated infective dermatitissyndrome. Mod Pathol 24(Suppl 1):126A, 2011.
Li-Ning-Tapia EM, Curry J, Zhang P, Prieto VG, Torres-Cabala CA. Epigenetics markers in acral lentiginous/mucosal melanoma: expression of EZH2. Mod Pathol 24(Suppl 1):119A-120A, 2011.
Wang W, Nero C, Patel K, Torres-Cabala C, Ivan D, Prieto V, Lopez-Terrada D, Lazar A. KIT amplification is uncommon in KIT mutation and wild type melanomas. J Cutan Pathol 38(1):89, 2011.
Torres-Cabala CA, Li-Ning-Tapia E, Ramos C, Curry JL, Prieto VG, Bravo F.. Evidence of regulatory T-cell immunophenotype in a subset of HTLV-1-associated infective dermatitis: an early sign or progression?. Mod Pathol 23(Suppl 1):123A, 2010.
Li-Ning-Tapia E, Wang WL, Curry JL, Prieto VG, Torres-Cabala CA. Expression of p16 and MITF-1 in acral lentiginous/mucosal melanomas. Mod Pathol 23(Suppl 1):119A, 2010.
Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D. Correlation between KIT protein expression and KIT mutation in melanoma. J Cutan Pathol 37(1):113, 2010.
Bejar Ardiles C, Vidarte Orrego G, Chian Garcia C,Torres-Cabala C.. Disseminated and extensive nodular syphilis with prozone phenomenon associated with HIV. ISDP. e-Pub 2009.
Plaza JA, Torres-Cabala C, Evans H, Diwan H, Prieto VG. Defining histopathologic criteria of cutaneous metastatic melanomas: a clinicopathologic study of 160 cases with emphasis on the morphologic spectrum. Mod Pathol 22:109A, 2009.
Plaza J, Torres-Cabala C, Prieto V. Is N-cadherin expression associated with impaired prognosis in melanoma? A tissue microarray analysis. J Cutan Pathol 36(1):173-174, 2009.
DeToro G, Chon S, Prieto VG, Torres-Cabala C. Melanoma in-situ colonizing basal cell carcinoma: a case report. ISDP, 2009.
Tapia ELN, Caramutti DM, Torres-Cabala C. Benign endocervical lesions in a population with high fecundity rates. Histopathology 53(Suppl 1):194, 2008.
Torres-Cabala CA, Plaza JA, Diwan AH, Prieto VG. Severe architectural disorder is a potential pitfall in the diagnosis of small dysplastic nevi. Mod Pathol 21(Suppl 1):102A, 2008.
Plaza JA, Torres-Cabala C, Ivan D, Prieto VG. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancies. Mod Pathol 21(Suppl 1):99A, 2008.
Plaza J, Torres-Cabala C, Prieto V. Malignant melanoma in association of a neurocrystic harmartoma. J Cutan Pathol 35(1):132, 2008.
Torres-Cabala CA, Plaza JA, Prieto VG. Angioimmunoblastic T-cell lymphoma presenting as a skin rash. J Cutan Pathol 35(1):123, 2007.
Torres-Cabala CA, Jaffe ES, Pittaluga S, Raffeld M, Salomon M, Bravo FG. Hydroa vacciniforme-like EBV-associated lymphoprolifeative disorder: report of a case with evidence of progression. Am J Dermatopath 29(2):204, 2007.
Torres-Cabala CA, DeWitt CA, Stabinski L, DeCastro R, Holland S, Turner ML, Lee CR. Acquired acrodermatitis enteropathica in a patient with multiple nutrient deficiencies after gastric bypass. Am J Dermatopath 29(2):205, 2007.
Torres-Cabala CA, Li Ning EML, Teller LS, Palau MA, Linehan WM, Merino MJ. Are some collecting duct carcinomas indeed HLRCC tumors?. Mod Pathol 19(Suppl 1):165A, 2006.
Palau MA, Torres-Cabala CA, Li Ning E, Linehan WM, Merino MJ. Detrmination of EGFR status in sporadic and hereditary renal tumors. Correlation between CISH and immunohistochemistry. Mod Pathol 19(Suppl 1):153A, 2006.
Merino MJ, Toro JR, Palau MA, Lineham WM, Torres-Cabala CA. The spectrum of morphologic features of renal tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome: Our experience with 34 cases. Mod Pathol 19(Suppl 1):150A, 2006.
Kim, CM, Vocke K, Torres-Cabala C, Yang YF, Walther MM, Linehan WM. Expression of hypoxia inducible factors in genetically distinct early renal cortical tumors. J Urol 173(4):95, 2005.
Grubb RL, Franks ME, Toro JR, Hurley K, Glenn GM, Choyke P, Coleman J, Torres-Cabala C, Merino MJ, Zbar B, Walther MM, Lineham WM. Hereditary leiomyomatosis and renal cell cancer (HLRCC): an aggressive form of inherited renal cancer. J Urol 173(4, Suppl S):379, 2005.
Isaacs JS, Jung YJ, Mole D, Lee S, Torres-Cabala CA, Marino M, Trepel J, Zbar B, Toro J, Ratcliffe P, Linehan M, Neckers L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability. Proc Amer Assoc Cancer Res 46:610, 2005.
Teller LS, Torres-Cabala C, Vocke C, Linehan WM, Sobel ME, Merino MJ. Molecular analysis of multi-focal tumors in a patient with Birt-Hogg-Dube syndrome. FASEB J 19(5, Suppl S, Part 2):A1533, 2005.
Torres-Cabala CA, Li Ning EML, Palau MA, Zbar B, Linehan WM, Merino MJ. Expression of KIT in hereditary renal cell carcinoma. Mod Pathol 18(Suppl 1):167A, 2005.
Deas-Wooten KD, Hermann PC, Torres-Cabala CA, Linehan WM, Merino MJ. Expression of oxidative complex enzymes assist in the differential diagnosis of renal tumors. Mod Pathol 18(Suppl 1):136A, 2005.
Palau M, Ronchetti R, Linehan WM, Li Ning EML, Torres-Cabala C, Merino MJ. Application of chromogenic in situ hybridization (CISH) in the differential diagnosis of renal tumors. Mod Pathol 18(Suppl 1):333A, 2005.
Ahmed A, Torres-Cabala C, Linehan M, Merino M, Tsokos M. Renal tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: Ultrastructural characterization. Mod Pathol 18(Suppl 1):337A, 2005.
Ning EL, Ronchetti R, Torres-Cabala CA, Teller LS. Chromogenic in situ hybridization (CISH), a helpful tool for the pathologist to identify HER2/NEU amplification in breast carcinoma. Comparative study with IHC and FISH. Mod Pathol 18(Suppl 1):40A, 2005.
Wei M, Torres-Cabala C, Nickerson M, Glenn G, Turner M, Linehan WM, Merino M, Schmidt L, Zbar B, Toro JR. Mutations in the fumarate hydratase causes hereditary leiomyomatosis and renal cell carcinoma in families in North America. Proc Amer Assoc Cancer Res 45:524, 2004.
Chian-Garcia CA, Torres-Cabala CA, Lozano Z, Wrathall LS, Merino MJ. Loss of heterozygosity of chromosome 9p21 and expression of p16 protein in acral melanomas. Mod Pathol 17:91A, 2004.
Torres-Cabala CA, Wrathall LS, Ronchetti RD, Chian CA, Sobel M, Linehan WM, Merino MJ. Molecular and cytogenetic profile of type 1 papillary renal cell carcinoma with clear cell differentiation: concurrence or tumor progression?. Mod Pathol 17:180A, 2004.
Chian-Garcia CA, Torres-Cabala CA, Otis C, Barazi H, Roberts DD, Merino MJ. The search for new potential markers in ovarian carcinoma through proteomic analysis. Mod Pathol 17:193A, 2004.
Mosquera JM, Torres-Cabala C, Chian-Garcia C, Otis C, Roberts D, Merino MJ. Identification of new markers in ovarian cancer with ptoential use in diagnosis and treatment. Mod Pathol 17:208A, 2004.
Torres-Cabala CA, Worrell RA, Chian-Garcia CA, Martinez A, Merino MJ, Linehan WM. Immunohistochemical expression of hypoxia-induced mediators and correlation with VHL gene mutation in sporadic clear cell renal carcinoma. Mod Pathol 16(1):173A, 2003.
Chian CA, Torres CA, Ronchetti RD, Linehan WM, Merino MJ. Immunohistochemical profile of Aquaporin-1, Tamm-Horsfall protein, and chloride channel-2 in subtypes of renal cell carcinoma. Proc Amer Assoc of Cancer Res 44:1243, 2003.
Chian-Garcia CA, Torres-Cabala CA, Eyler R, Linehan WM, Merino MJ. Renal cell carcinoma in children and young adults: A clinicopathological and immunohistochemical study of 14 cases. Mod Pathol 16(1):145A, 2003.
Ronchetti RD, Torres-Cabala CA, Chian-Garcia CA, Duray PH, Philips J, Linehan WM. Expression of estrogen receptor alpha and beta, androgen receptor, and glutathione-s-transferase π in prostatic adenocarcinoma. Mod Pathol 16(1):167A, 2003.
Ronchetti RD, Torres-Cabala CA, Chian-Garcia CA, Eyler R, Linehan WM, Merino MJ. Detection of chromosome 7 and 17 aneuploidy in type 1 papillary renal cell carcinoma by chromogenic in situ hybridization (CISH). A comparison with other renal cell tumors. Mod Pathol 16(1):167A, 2003.
Merino MJ, Torres-Cabala CA, Zbar B, Chian-Garcia C, Lineham WM. Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC): clinical histopathological and molecular features of the first American families described. Mod Pathol 16(1):162A, 2003.
Bravo F, Torres-Cabala C, Munoz S. The spectrum of palisaded granulomas and "necrobiosis" in patients with arthritis. Am J Dermatopath 21(1):75, 1999.

Book Chapters

Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Ivan D, Curry JL, Aung PP, Prieto VG. Skin. In: Oncological Surgical Pathology. Springer: Switzerland, 2020.
Torres-Cabala CA, Modi MB, Junkins-Hopkins JM. T cell disorders. In: Dermatopathology for Residents, 2019.
Berti E, Willemze R, Guitart J, Jaffe ES, Kempf W, Petrella T, Robson A, Cerroni L, Torres-Cabala CA. Primary cutaneous peripheral T-cell lymphomas, rare subtypes. In: WHO Classification of Skin Tumors. IARC Press: Lyon, France, 2018.
Danialan R, Torres-Cabala CA. Cutaneous Manifestations of Myeloproliferative Neoplasms. In: Hematopathology of the Skin. Wolters Kluwer: New York, 537-549, 2017.
Torres-Cabala CA, Tetzlaff MT, Curry JL. Biomarker Analysis of Gene-Mutated Protein Products by Immunohistochemistry in Melanoma. In: Genetics of Melanoma. Springer: New York, 181-191, 2016.
Torres-Cabala CA, Aung P, Miranda RN, Curry JL. Immunohistology and Molecular Studies of Cutaneous T-Cell Lymphomas and Mimics. In: Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. Springer International: Switzerland, 229-259, 2016.
Curry JL, Tetzlaff MT, Nagarajan P, Torres-Cabala CA. Immunohistology of Melanocytic Lesions. In: Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. Springer International: Switzerland, 311-334, 2016.
Curry JL, Ciurea AM, Nagarajan P, Torres-Cabala CA. Dermatologic toxicities to Melanoma Targeted Therapies. In: Genetics in Melanoma. Springer: New York, 267-277, 2016.
Torres-Cabala CA, Curry JL, Chenn SS, Miranda RN. Hematolymphoid Proliferations of the Skin. In: Precision Molecular Pathology of Dermatologic Diseases. Springer Science: New York, 2015.
Torres-Cabala CA, Mutyambizi K, Bravo F. Infectious Diseases of the Skin. In: Precision Molecular Pathology of Dermatologic Diseases. Springer Science: New York, 2015.
Curry JL, Torres-Cabala C, Prieto VG. Histopathology of Nonmelanoma Skin Cancer. In: Cutaneous Malignancy of the Head and Neck: A multidisciplinary approach. 1st. Plural Publishing Inc, 2011.
Quezado M, Torres-Cabala CA, Berman D. Molecular Pathology in Life-Cycle Management in Drug Development. In: Molecular Pathology in Drug Discovery and Development. 1st. John Wiley & Sons: Hoboken, NJ, 169-185, 2009.
Li-Ning E, Torres-Cabala C. Dysplastic Nevus Syndrome. In: Encyclopedia of Pathology. 1st. Springer-Verlag: Heidelberg, Germany, 2009.
Merino MJ, Torres-Cabala CA. Pathology of Inherited Forms of Renal Carcinoma. In: Comprehensive Textbook of Genitourinary Oncology. 3rd. Lippincott Williams and Wilkins: Philadelphia, PA, 697-700, 2006.
Torres-Cabala, CA Moran, C. Kalhor N, Weissferdt A.. Hematolymphoid neoplasms of the skin. In: Oncological Surgical Pathology Practice at MD Anderson Cancer Center. Springer International Publishing: New York.
Pulitzer M, Kempf W, Guitart J, Torres-Cabala CA, Willemze R. Primary cutaneous gd T Cell lymphoma. In: WHO Classification of Skin Tumors. IARC Press: Lyon, France.

Books (edited and written)

Torres-Cabala CA, Curry JL. Genetics of Melanoma. Ed(s) Torres-Cabala CA, Curry JL. Springer: New York, 2016.

Letters to the Editor

Plaza JA, Torres-Cabala CA, Ivan D, Prieto VG. Reply. J Cutan Pathol 37: 916, 2010.

Less

Grant & Contract Support

Date:	2018 - 2021
Title:	Comprehensive molecular and immune profiling of primary acral melanoma from various ethnic groups
Funding Source:	Melanoma Research Alliance
Role:	Mentor

CV information above last modified June 27, 2024

Carlos Antonio Torres-Cabala, M.D.

About Dr. Torres-Cabala

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Consultantships

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Editorials

Abstracts

Book Chapters

Books (edited and written)

Letters to the Editor

Grant & Contract Support

Patient Reviews

Related Links

Translational Molecular Pathology-Dermatopathology Laboratory (TMP-DL)

Help #EndCancer

Carlos Antonio Torres-Cabala, M.D.

About Dr. Torres-Cabala

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Consultantships

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Editorials

Abstracts

Book Chapters

Books (edited and written)

Letters to the Editor

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Translational Molecular Pathology-Dermatopathology Laboratory (TMP-DL)

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer